This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Lung cancer and mesothelioma
LUNG_CANCER_MESOT
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
10279 |
4. Check minimum number of eventsNone |
10279 |
5. Include endpointsNone |
10279 |
6. Filter based on genotype QC (FinnGen only) |
10279 |
Control definitions (FinnGen only)
- Control exclude
- ASTHMA_EXCL
Extra metadata
- First used in FinnGen datafreeze
- DF2
Lung cancer and mesothelioma
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 10279 | 2853 | 7426 |
| Unadjusted period prevalence (%) | 2.63 | 0.97 | 3.27 |
| Median age at first event (years) | 71.64 | 69.42 | 72.50 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 5872
- Matched controls
- 56818
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
323.0
702
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
323.0
1318
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
10.9
323.0
970
1016
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
5219.5
323.0
505
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
323.0
645
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
165.4
323.0
984
69
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
18.5
323.0
1167
752
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
323.0
392
*
H02AB02
ATC
dexamethasone; systemic
11.2
323.0
2152
2795
J45.9
ICD-10 Finland
Asthma, unspecified
11.1
323.0
928
940
H02AB06
ATC
prednisolone; systemic
3.8
323.0
3232
13787
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
323.0
438
*
JN4BD
NOMESCO Finland
Extensive body CT
5.5
323.0
1562
3515
GDC00
NOMESCO Finland
Lobectomy of lung
455.4
323.0
479
11
N02AA05
ATC
oxycodone; systemic
8.0
323.0
2226
4043
J18.9
ICD-10 Finland
Pneumonia, unspecified
35.5
323.0
2458
1129
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
125.6
323.0
411
34
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
43.1
323.0
453
110
WF004
NOMESCO Finland
Palliative radiotherapy
25.5
323.0
757
328
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
323.0
367
*
A03FA01
ATC
metoclopramide; systemic, rectal
6.9
323.0
2664
6097
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
59.2
323.0
3288
1192
R03AK06
ATC
salmeterol and fluticasone; inhalant
7.2
323.0
966
1514
UGC12
NOMESCO Finland
Flexible bronchoscopy
80.5
323.0
2523
526
J01MA14
ATC
moxifloxacin; systemic
8.7
323.0
843
1078
WF049
NOMESCO Finland
Radiotherapy of metastasis
19.3
323.0
1125
688
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
125.4
323.0
574
49
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
2047.7
323.0
415
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
218.1
323.0
1918
126
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
58.3
323.0
1652
378
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
3760.7
323.0
375
*
R03BB04
ATC
tiotropium bromide; inhalant
28.6
323.0
1327
574
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
63.3
323.0
515
86
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
8.0
323.0
1161
1689
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.5
323.0
3784
16288
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
+∞
323.0
435
*
L01CA04
ATC
vinorelbine; systemic
164.2
323.0
568
37
R84
ICPC
Malignant neoplasm bronchus/lung
669.8
323.0
328
5
Z51.5
ICD-10 Finland
Palliative care
11.9
323.0
1403
1459
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.9
323.0
1644
4160
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
7.7
323.0
1105
1656
R03AC02
ATC
salbutamol; inhalant
3.7
323.0
3115
13391
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
323.0
702
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
323.0
604
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
70.8
323.0
755
118
130
Kela drug reimbursment
Malignant tumour
23.4
323.0
3025
2468
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
55.9
323.0
464
87
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
58.5
323.0
882
171
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
807.3
323.0
919
13
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
17.5
323.0
675
419
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
40.7
323.0
423
108
GD1AD
NOMESCO Finland
Thorax CT examination
20.2
323.0
939
529
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
323.0
810
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
632.3
323.0
695
12
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
+∞
323.0
423
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
323.0
726
*
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
+∞
323.0
333
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
323.0
512
*
A04AA01
ATC
ondansetron; systemic, rectal
10.2
323.0
1259
1477
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
+∞
316.7
305
*
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
107.4
312.6
345
33
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
+∞
310.4
299
*
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
+∞
303.1
292
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
18.3
302.7
486
278
J94.8
ICD-10 Finland
Other specified pleural conditions
743.6
295.8
293
*
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
294.7
284
*
WZC30
NOMESCO Finland
Teaching
3.9
294.2
1431
4318
R06.0
ICD-10 Finland
Dyspnoea
3.4
293.6
1756
6274
XX3DW
NOMESCO Finland
Time consuming IT work
4.2
286.4
1268
3504
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
22.5
282.0
422
195
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
8.4
278.2
654
832
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
52.4
277.2
338
66
J01MA12
ATC
levofloxacin; systemic
3.6
274.3
1486
4870
XG410
NOMESCO Finland
Flow-volume spirometry
16.1
272.4
459
297
WF002
NOMESCO Finland
Radical radiotherapy
5.3
271.8
925
1942
JN4AD
NOMESCO Finland
Body CT examination
4.9
271.7
1005
2312
TGD00
NOMESCO Finland
Needle biopsy of lung
152.9
267.7
286
19
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
+∞
266.5
257
*
J45.1
ICD-10 Finland
Nonallergic asthma
36.7
264.9
347
97
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
6.1
257.5
767
1366
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
+∞
257.0
248
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
8.8
249.8
568
680
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
+∞
244.5
236
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
16.0
240.7
406
262
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
5.4
238.1
790
1596
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.6
237.7
2433
12033
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
+∞
233.0
225
*
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
200.6
228.1
239
12
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
17.2
228.0
374
224
L01CB01
ATC
etoposide; systemic
93.9
223.9
251
27
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.4
223.7
904
2244
R04.2
ICD-10 Finland
Haemoptysis
11.8
223.3
431
378
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
7.7
222.1
553
761
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
22.2
221.4
332
153
ZX120
NOMESCO Finland
Intravenous
4.4
217.7
880
2181
C45.0
ICD-10 Finland
Mesothelioma of pleura
721.0
217.5
216
*
C34.16
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma
+∞
215.3
208
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
6.4
211.3
602
1001
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
+∞
209.0
202
*
A04AA02
ATC
granisetron; systemic, transdermal
4.9
208.2
744
1620
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.9
207.9
985
2817
C03CA01
ATC
furosemide; systemic
2.6
207.8
1996
9341
TGC00
NOMESCO Finland
Bronchial lavation
34.5
205.7
273
80
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
194.2
202.8
213
11
TGA30
NOMESCO Finland
Thoracocentesis
262.3
202.6
209
8
R03AK07
ATC
formoterol and budesonide; inhalant
3.7
199.7
1001
2994
TPH04
NOMESCO Finland
Cathetrisation of vein
2.8
196.9
1566
6512
A04AA55
ATC
palonosetron, combinations; systemic
9.1
194.6
432
491
A02BC02
ATC
pantoprazole; systemic
2.3
194.2
3989
27081
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.3
192.6
2716
15380
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
49.6
188.5
232
47
C34.86
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary microcellular carcinoma
+∞
188.2
182
*
R95
ICPC
Chron obstructive pulmonary disease
18.1
187.9
302
170
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
8.5
186.1
430
522
C34.81
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma
+∞
180.9
175
*
R4110
NOMESCO Finland
Physiotherapy
2.5
180.9
1929
9403
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
446.5
178.6
180
*
N02AX02
ATC
tramadol; systemic, rectal
2.2
177.2
2756
16128
N03AX16
ATC
pregabalin; oral
2.6
176.7
1613
7201
B01AB05
ATC
enoxaparin; parenteral
2.3
176.6
2274
12162
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
64.4
174.8
206
32
AA1BD
NOMESCO Finland
Extensive CT of head and brain
8.0
172.7
413
529
WX892
NOMESCO Finland
Monitored bed care
4.2
169.9
707
1777
J45.0
ICD-10 Finland
Predominantly allergic asthma
18.9
169.0
267
143
J96.1
ICD-10 Finland
Chronic respiratory failure
+∞
168.5
163
*
J93.8
ICD-10 Finland
Other pneumothorax
1694.6
167.3
164
*
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
19.6
162.4
253
130
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
12.1
158.7
301
252
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
157.8
1132
4328
N07BA03
ATC
varenicline; oral
7.2
157.5
406
581
C34.22
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma
+∞
155.0
150
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
17.6
154.5
250
143
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
153.1
1859
9506
A98
ICPC
Health maint/preventive medicine
0.4
149.2
4501
50715
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
9.9
148.6
312
319
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.4
147.7
590
1417
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
+∞
147.7
143
*
J43.9
ICD-10 Finland
Emphysema, unspecified
72.8
145.2
168
23
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
291.4
142.2
146
5
XF400
NOMESCO Finland
ECG with 12 standard connections
2.6
140.3
1192
5011
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
101.9
138.7
154
15
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
9.7
137.6
292
304
C34.01
ICD-10 Finland
Malignant tumor of the main bronchial epidermoid carcinoma
+∞
137.3
133
*
C34.0
ICD-10 Finland
Malignant neoplasm: Main bronchus
+∞
137.3
133
*
N02AA01
ATC
morphine; systemic, rectal
17.3
133.3
217
126
155
Kela drug reimbursment
Afatinib and gefitinib
+∞
133.2
129
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
7.3
133.1
337
468
1BA04
NOMESCO Finland
NA
+∞
131.1
127
*
A06AH03
ATC
naloxegol; oral
13.8
130.1
232
169
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.6
128.3
481
1080
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
150.6
128.0
137
9
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
3.2
126.5
731
2383
C34.91
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma
+∞
125.9
122
*
R50.9
ICD-10 Finland
Fever, unspecified
3.0
125.8
804
2813
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
78.8
125.0
143
18
C34.36
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma
+∞
123.8
120
*
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
41.8
122.9
156
37
J86.9
ICD-10 Finland
Pyothorax without fistula
+∞
121.8
118
*
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
308.9
121.1
124
*
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
27.5
120.7
169
61
8041/3-C34.1
ICD-O-3
Small cell carcinoma, NOS, of upper lobe, lung
+∞
117.6
114
*
A06AD11
ATC
lactulose; oral
2.7
117.3
954
3870
N05CF01
ATC
zopiclone; oral
2.0
117.2
1956
11204
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
8.5
116.0
266
316
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
86.4
115.8
131
15
191
Kela drug reimbursment
Erlotinib
91.8
115.8
130
14
GAC01
NOMESCO Finland
Endoscopic biopsy of pleura
565.2
114.9
115
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
5.2
113.3
374
730
R02
ICPC
Shortness of breath/dyspnoea
3.0
111.2
730
2585
R03BA02
ATC
budesonide; inhalant
2.9
110.9
745
2679
C34.20
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung without histology
+∞
110.4
107
*
J34.2
ICD-10 Finland
Deviated nasal septum
73.9
110.1
127
17
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
24.3
109.6
159
65
R03DA04
ATC
theophylline; systemic, rectal
7.6
109.1
268
355
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
13.6
107.3
192
141
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
19.7
106.6
165
83
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
24.0
106.6
155
64
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
21.9
106.3
159
72
J45.8
ICD-10 Finland
Mixed asthma
39.6
106.0
136
34
GAC00
NOMESCO Finland
Biopsy of pleura
1022.4
105.3
104
*
C34.15
ICD-10 Finland
Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma
+∞
105.2
102
*
C34.89
ICD-10 Finland
Malignant overall tumor of the bronchus and lung other or unspecified histology
+∞
105.2
102
*
J01AA02
ATC
doxycycline; systemic
1.9
105.0
4256
32976
ZX050
NOMESCO Finland
Stereotactic radiotherapy
13.1
102.5
186
141
GD2CT
NOMESCO Finland
Cytology of the lungs with CT guidance
210.7
102.5
107
5
J93.9
ICD-10 Finland
Pneumothorax, unspecified
+∞
101.1
98
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
7.7
100.3
244
318
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
100.2
1061
4916
B01AB10
ATC
tinzaparin; parenteral
3.1
99.2
595
1974
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
79.6
99.0
113
14
GD2AT
NOMESCO Finland
Cytology of the lungs with ultrasound guidance
202.7
98.4
103
5
C34
ICD-10 Finland
Malignant neoplasm of bronchus and lung
952.3
98.1
97
*
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
97.6
97.8
109
11
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
18.1
97.2
155
85
C34.2
ICD-10 Finland
Malignant neoplasm: Middle lobe, bronchus or lung
+∞
96.9
94
*
Z72.0
ICD-10 Finland
Tobacco use
9.7
96.8
204
209
R03AC13
ATC
formoterol; inhalant
7.1
96.4
247
348
WX250
NOMESCO Finland
Intercostal blockade
68.8
96.3
112
16
J37.0
ICD-10 Finland
Chronic laryngitis
26.4
96.2
136
51
GEA00
NOMESCO Finland
Mediastinoscopy
82.6
96.0
109
13
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
7.6
95.3
233
306
C34.96
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary microcellular carcinoma
+∞
94.9
92
*
L01XE03
ATC
[U] erlotinib; oral
112.6
93.9
103
9
R81
ICPC
Pneumonia
8.1
93.7
220
271
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
47.2
92.9
115
24
R03BA05
ATC
fluticasone; inhalant
2.7
92.9
717
2793
R03BB01
ATC
ipratropium bromide; inhalant
7.3
92.8
234
322
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
92.6
782
3207
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.2
92.3
537
1737
D70.82
ICD-10 Finland
Drug-induced neutropenia
9.7
92.3
195
201
J01FA06
ATC
roxithromycin; oral
1.8
91.3
2003
12419
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
10.7
90.3
181
169
R03AK08
ATC
formoterol and beclometasone; inhalant
13.4
90.2
162
120
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
72.5
89.2
103
14
9052/3-C38.4
ICD-O-3
Epithelioid mesothelioma, malignant of pleura, NOS
+∞
88.7
86
*
C34.17
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary carcinoid
+∞
86.6
84
*
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
+∞
86.6
84
*
L03AA13
ATC
pegfilgrastim; parenteral
4.3
85.9
337
785
R03BA01
ATC
beclometasone; inhalant
2.9
85.8
584
2100
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
42.5
85.6
108
25
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.0
85.5
530
1791
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
14.4
85.0
148
102
JN4CD
NOMESCO Finland
Very extensive body CT
3.8
84.8
391
1055
WW500
NOMESCO Finland
Blood transfusion
4.3
84.6
336
792
C34.21
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung epidermoid carcinoma
+∞
84.5
82
*
8000/3-C34.1
ICD-O-3
Neoplasm, malignant of upper lobe, lung
+∞
83.5
81
*
L01XE13
ATC
[U] afatinib; oral
+∞
83.5
81
*
9050/3-C38.4
ICD-O-3
Mesothelioma, malignant of pleura, NOS
+∞
82.5
80
*
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
51.7
82.2
100
19
A04AD12
ATC
aprepitant; systemic
6.4
82.2
226
351
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
11.5
80.7
155
133
C34.02
ICD-10 Finland
Malignant tumor of the main bronchial adenocarcinoma
+∞
80.4
78
*
J45
ICD-10 Finland
Asthma
4.0
80.0
345
877
H02AB07
ATC
prednisone; oral
2.4
79.6
728
3101
R03AC03
ATC
terbutaline; inhalant
2.8
79.6
578
2158
R03AC12
ATC
salmeterol; inhalant
7.7
79.6
192
247
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
30.4
79.4
108
35
C34.37
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung carcinoid
+∞
79.4
77
*
R03DC03
ATC
montelukast; oral
2.9
77.8
509
1780
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
8.1
77.6
181
221
C34.35
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma
+∞
77.3
75
*
GDD00
NOMESCO Finland
Pneumonectomy
+∞
75.2
73
*
J96.0
ICD-10 Finland
Acute respiratory failure
+∞
75.2
73
*
GAA31
NOMESCO Finland
Thoracoscopy
58.2
74.7
89
15
J46
ICD-10 Finland
Status asthmaticus
33.5
74.6
99
29
J94.9
ICD-10 Finland
Pleural condition, unspecified
130.7
74.0
80
6
8010/3-C34.9
ICD-O-3
Carcinoma, NOS, of lung, NOS
+∞
73.2
71
*
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
34.6
72.1
95
27
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
+∞
72.1
70
*
3004
Kela drug reimbursment
Osimertinib
+∞
72.1
70
*
8041/3-C34.3
ICD-O-3
Small cell carcinoma, NOS, of lower lobe, lung
+∞
71.1
69
*
R05
ICD-10 Finland
Cough
2.1
71.0
976
5002
ZX070
NOMESCO Finland
Intensity modified radiotherapy
4.4
70.9
272
619
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
4.4
69.2
267
611
N05BA04
ATC
oxazepam; oral
1.9
68.8
1258
7186
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
10.5
68.6
138
130
GDC10
NOMESCO Finland
Bilobectomy of lung
+∞
68.0
66
*
DJD20
NOMESCO Finland
Plastic repair of septum of nose
40.1
67.5
86
21
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
9.2
67.5
146
157
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
+∞
64.9
63
*
1519
Kela drug reimbursment
NA
+∞
64.9
63
*
341
Kela drug reimbursment
Afatinib and gefitinib
+∞
64.9
63
*
C34.06
ICD-10 Finland
Malignant tumor of the main bronchial microcellular carcinoma
+∞
64.9
63
*
M05BX04
ATC
denosumab; parenteral
3.1
64.6
391
1293
I50.9
ICD-10 Finland
Heart failure, unspecified
2.3
64.3
678
3080
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
4.7
63.2
225
475
A79
ICPC
Malignancy NOS
6.3
63.1
175
275
J47
ICD-10 Finland
Bronchiectasis
112.5
63.0
69
6
8140/3-C34.2
ICD-O-3
Adenocarcinoma, NOS, of middle lobe, lung
+∞
62.8
61
*
C34.09
ICD-10 Finland
Malignant tumor of the main bronchus other or unspecified histology
+∞
62.8
61
*
B01AB04
ATC
dalteparin; parenteral
3.1
62.4
375
1235
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
161.3
62.2
66
*
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
110.9
62.0
68
6
TDM10
NOMESCO Finland
Puncture of maxillary antrum
25.4
61.9
88
34
A28
ICPC
Limited function/disability NOS
2.0
61.1
899
4709
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
14.9
60.4
103
68
A07AA02
ATC
nystatin; oral
3.0
60.3
373
1252
R85
ICPC
Malignant neopl respiratory other
83.2
60.1
68
8
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
37.7
59.8
77
20
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
57.9
59.7
71
12
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.7
58.6
423
1566
N02BE01
ATC
paracetamol; systemic, rectal
1.7
58.2
4847
41536
D38.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified
123.1
58.1
63
5
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.7
57.7
440
1682
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
57.7
1340
8210
WX402
NOMESCO Finland
General anaesthesia
1.9
57.1
953
5224
L01EB04
ATC
osimertinib; oral
+∞
56.6
55
*
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
13.0
56.5
102
77
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
3.1
56.3
339
1115
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
55.8
1536
9879
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.8
55.3
393
1441
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.4
55.0
288
857
J01FF01
ATC
clindamycin; systemic
1.7
54.7
1345
8363
R03AC18
ATC
indacaterol; inhalant
30.2
54.6
74
24
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.6
54.5
946
14156
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
5.7
53.7
160
276
R03BA08
ATC
ciclesonide; inhalant
3.3
53.6
289
879
8240/3-C34.9
ICD-O-3
Neuroendocrine tumor, NOS, of lung, NOS
+∞
53.5
52
*
R96
ICPC
Asthma
3.2
53.4
304
962
J33.0
ICD-10 Finland
Polyp of nasal cavity
21.2
53.4
80
37
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
6.6
52.5
140
209
8551/3-C34.1
ICD-O-3
Acinar cell cystadenocarcinoma of upper lobe, lung
+∞
52.5
51
*
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
45.3
52.5
65
14
R06.2
ICD-10 Finland
Wheezing
5.0
52.2
176
351
XG466
NOMESCO Finland
Sleep oxymetry
4.5
52.0
194
430
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
51.5
1094
6486
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
259.3
51.5
53
*
J01CA04
ATC
amoxicillin; systemic
1.5
51.2
3953
32456
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
5.9
51.2
148
246
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
18.9
50.8
79
41
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
50.7
1746
11869
J98.1
ICD-10 Finland
Pulmonary collapse
254.2
50.5
52
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
50.1
689
3495
J01DA01
ATC
[U] cefalexin; systemic
1.5
48.9
3084
24071
J20
ICD-10 Finland
Acute bronchitis
2.4
48.8
445
1871
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.2
48.8
269
832
A02BC01
ATC
omeprazole; systemic
1.6
48.7
1442
9404
C34.29
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung other or unspecified histology
+∞
48.4
47
*
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
165.8
48.2
51
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
8.3
48.1
110
131
1CD01
NOMESCO Finland
NA
22.8
47.9
70
30
8240/3-C34.3
ICD-O-3
Neuroendocrine tumor, NOS, of lower lobe, lung
+∞
47.4
46
*
GCA32
NOMESCO Finland
Endoscopic insertion of stent into bronch
+∞
47.4
46
*
L03AA02
ATC
filgrastim; parenteral
3.9
47.2
204
519
J31.0
ICD-10 Finland
Chronic rhinitis
4.2
47.1
186
436
AA1AD
NOMESCO Finland
CT of head and brain
1.6
46.8
1351
8731
XF600
NOMESCO Finland
Bloodpressure measurement
2.6
46.6
376
1482
C07AB07
ATC
bisoprolol; oral
1.5
46.4
2792
21468
D38.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pleura
74.0
46.3
53
7
R03AK11
ATC
formoterol and fluticasone; inhalant
8.2
46.2
106
127
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
33.1
46.1
61
18
B03BA03
ATC
hydroxocobalamin; parenteral
2.5
45.8
394
1605
R52.0
ICD-10 Finland
Acute pain
4.1
45.7
185
444
C34.85
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary other non-microcellular carcinoma
+∞
45.3
44
*
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
155.9
45.2
48
*
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
155.9
45.2
48
*
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
83.0
45.2
51
6
PJD99
NOMESCO Finland
Excision of other lymph nodes
37.8
45.2
58
15
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
15.7
44.6
74
46
N05AD01
ATC
haloperidol; systemic
4.0
44.1
183
449
XG405
NOMESCO Finland
Education on PEF monitoring
15.2
43.4
73
47
C38.4
ICD-10 Finland
Malignant neoplasm: Pleura
+∞
43.2
42
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
3.6
42.8
204
564
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
42.5
462
2114
J36
ICD-10 Finland
Peritonsillar abscess
32.1
42.1
56
17
L03AA14
ATC
lipegfilgrastim; parenteral
4.4
42.1
158
353
N05BA06
ATC
lorazepam; systemic, sublingual
2.8
41.6
279
984
JN6AD
NOMESCO Finland
CT of torso and neck
5.6
41.6
126
223
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.1
41.1
234
740
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
41.0
585
2999
ZX095
NOMESCO Finland
Combined chemoradiotherapy
7.4
40.8
100
133
GDC20
NOMESCO Finland
Lobectomy of lung and sleeve resection of bronchus
396.9
40.6
41
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.3
40.5
211
626
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
204.4
40.3
42
*
ZXA00
NOMESCO Finland
Right side
1.5
40.3
1534
10560
L01XE02
ATC
[U] gefitinib; oral
+∞
40.1
39
*
GD2FN
NOMESCO Finland
Lung ventilation distribution isotope examination (radiospirometry)
+∞
40.1
39
*
8000/3-C34.3
ICD-O-3
Neoplasm, malignant of lower lobe, lung
+∞
40.1
39
*
J43.2
ICD-10 Finland
Centrilobular emphysema
+∞
40.1
39
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.6
40.0
316
1229
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
57.2
39.6
47
8
WW200
NOMESCO Finland
Immunization
4.1
39.6
159
379
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
39.5
594
3107
J01FA09
ATC
clarithromycin; systemic
1.6
39.4
1297
8614
8041/3-C34.0
ICD-O-3
Small cell carcinoma, NOS, of main bronchus
+∞
39.1
38
*
J33.8
ICD-10 Finland
Other polyp of sinus
37.5
39.0
50
13
H02AB04
ATC
methylprednisolone; systemic
2.0
38.8
577
3003
R06AE07
ATC
cetirizine; oral
1.5
38.7
1799
12931
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
38.7
1791
12863
C34.14
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary macrocellular anaplastic carcinoma
+∞
38.1
37
*
8070/3-C34.0
ICD-O-3
Squamous cell carcinoma, NOS, of main bronchus
+∞
38.1
37
*
Z57.2
ICD-10 Finland
Occupational exposure to dust
49.8
37.9
46
9
WX600
NOMESCO Finland
Single shot through catheter
5.3
37.3
118
220
R05
ICPC
Cough
1.7
37.3
979
6113
SPAT1109
SPAT
Analgesia with portable analgesic pump
7.9
37.0
86
106
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
5.2
36.9
119
227
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
5.9
36.7
106
177
R03BB07
ATC
umeclidinium bromide; inhalant
17.7
36.7
58
32
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.6
36.3
1165
7664
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
184.8
36.3
38
*
C34.13
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary bronchoalveolar carcinoma
+∞
36.0
35
*
C34.97
ICD-10 Finland
Malignant tumor in unspecified location in bronchial and pulmonary carcinoid
+∞
36.0
35
*
3001
Kela drug reimbursment
Alectinib
+∞
36.0
35
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
35.9
1011
6430
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
7.0
35.9
91
128
ZX080
NOMESCO Finland
Image guided radiotherapy
3.4
35.7
183
537
J38.1
ICD-10 Finland
Polyp of vocal cord and larynx
347.7
35.5
36
*
A02BA02
ATC
ranitidine; systemic
1.6
35.2
1030
6614
ZXA05
NOMESCO Finland
Left side
1.5
35.2
1420
9852
TKC20
NOMESCO Finland
Catheterisation of bladder
2.1
35.1
414
1958
1504
Kela drug reimbursment
Alectinib
+∞
35.0
34
*
C34.26
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung microcellular carcinoma
+∞
35.0
34
*
XX1XW
NOMESCO Finland
Extensive written report from radiologist
4.2
34.9
136
316
GDB10
NOMESCO Finland
Wedge resection of lung
32.0
34.7
46
14
J34.1
ICD-10 Finland
Cyst and mucocele of nose and nasal sinus
45.4
34.1
42
9
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
5.8
34.1
99
167
GDC11
NOMESCO Finland
Thoracoscopic bilobectomy of lung
+∞
34.0
33
*
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
26.9
34.0
47
17
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
31.3
33.8
45
14
RS221
NOMESCO Finland
NA
6.0
33.7
96
158
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
0.7
33.1
1765
21569
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.3
33.1
315
1350
8551/3-C34.3
ICD-O-3
Acinar cell cystadenocarcinoma of lower lobe, lung
+∞
32.9
32
*
D86.0
ICD-10 Finland
Sarcoidosis of lung
+∞
32.9
32
*
L01XX17
ATC
[U] topotecan; systemic
+∞
32.9
32
*
GA2AT
NOMESCO Finland
Pleural biopsy with ultrasound guidance
+∞
32.9
32
*
348
Kela drug reimbursment
Roflumilast
+∞
32.9
32
*
C34.33
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung bronchoalveolar carcinoma
+∞
32.9
32
*
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
48.6
32.9
40
8
SPAT1255
SPAT
Intravenous administration of medicine
2.2
32.5
354
1615
GCA05
NOMESCO Finland
Bronchoscopic laser therapy of lesion of bronchus
318.2
32.5
33
*
R03AL04
ATC
indacaterol and glycopyrronium bromide; inhalant
21.3
32.4
48
22
J92.9
ICD-10 Finland
Pleural plaque without asbestos
72.1
32.4
37
5
SPAT1254
SPAT
Administration of medicine
1.7
32.3
708
4184
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
28.6
32.3
44
15
SPAT1059
SPAT
Spirometry at the office
2.6
32.1
249
958
8240/3-C34.1
ICD-O-3
Neuroendocrine tumor, NOS, of upper lobe, lung
+∞
31.9
31
*
8070/3-C34.2
ICD-O-3
Squamous cell carcinoma, NOS, of middle lobe, lung
+∞
31.9
31
*
8480/3-C34.3
ICD-O-3
Mucinous adenocarcinoma of lower lobe, lung
+∞
31.9
31
*
8046/3-C34.9
ICD-O-3
Non-small cell carcinoma of lung, NOS
+∞
31.9
31
*
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
26.8
31.8
44
16
A03
ICPC
Fever
1.9
31.8
522
2807
WW200
SPAT
NA
0.4
31.8
127
3061
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
3.3
31.7
165
491
N05BA01
ATC
diazepam; systemic, rectal
1.8
31.6
618
3526
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.7
31.5
1323
16873
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
31.5
2204
16996
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
5.7
31.2
91
155
N03AX14
ATC
levetiracetam; systemic
3.4
30.9
157
458
WX330
NOMESCO Finland
Paravertebral ansthesia
+∞
30.9
30
*
J01DB01
ATC
cefalexin; oral
1.4
30.8
4182
36134
R28
ICPC
Limited function/disability (R)
6.5
30.8
82
124
J35.0
ICD-10 Finland
Chronic tonsillitis
23.8
30.8
44
18
WX725
NOMESCO Finland
Noninvasive ventilation
2.6
30.7
233
885
DHB20
NOMESCO Finland
Polypectomy of internal nose
38.0
30.6
39
10
R24
ICPC
Haemoptysis
9.9
30.5
62
61
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
9.9
30.5
62
61
P01AB01
ATC
metronidazole; oral, rectal
1.4
30.4
1764
13118
1BC05
NOMESCO Finland
NA
107.0
30.2
33
*
L01ED03
ATC
alectinib; oral
+∞
29.8
29
*
L01XE35
ATC
[U] osimertinib; oral
+∞
29.8
29
*
169
Kela drug reimbursment
Crizotinib
+∞
29.8
29
*
J93.0
ICD-10 Finland
Spontaneous tension pneumothorax
+∞
29.8
29
*
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
+∞
29.8
29
*
R03DX07
ATC
roflumilast; oral
+∞
29.8
29
*
J38.3
ICD-10 Finland
Other diseases of vocal cords
37.0
29.7
38
10
XG460
NOMESCO Finland
Short time oxymetry
5.4
29.6
91
165
N06AX11
ATC
mirtazapine; oral
1.5
29.4
1389
9907
C45.9
ICD-10 Finland
Mesothelioma, unspecified
150.6
29.3
31
*
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
11.4
29.1
55
47
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
18.3
29.0
45
24
J34.3
ICD-10 Finland
Hypertrophy of nasal turbinates
48.6
28.9
35
7
C34.95
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other non-microcellular carcinoma
+∞
28.8
28
*
C34.27
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung carcinoid
+∞
28.8
28
*
N06AB04
ATC
citalopram; systemic
1.6
28.8
892
5782
DHB50
NOMESCO Finland
Turbinoplasty
15.8
28.7
47
29
K05.31
ICD-10 Finland
Periodontitis pronounced
1.8
28.6
575
3304
I50.0
ICD-10 Finland
Congestive heart failure
2.2
28.6
290
1282
R03BB06
ATC
glycopyrronium bromide; inhalant
30.8
28.5
38
12
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.7
28.4
999
13206
GDA10
NOMESCO Finland
Biopsy of lung
77.8
28.3
32
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
5.4
27.9
86
157
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.3
27.8
269
1162
8250/3-C34.9
ICD-O-3
Lepidic adenocarcinoma of lung, NOS
+∞
27.8
27
*
8046/3-C34.1
ICD-O-3
Non-small cell carcinoma of upper lobe, lung
+∞
27.8
27
*
L01EB03
ATC
afatinib; oral
+∞
27.8
27
*
R11
ICD-10 Finland
Nausea and vomiting
2.1
27.7
340
1635
R05FB02
ATC
cough suppressants and expectorants
1.4
27.6
1837
13947
A41.9
ICD-10 Finland
Sepsis, unspecified
3.0
27.4
165
545
J43.8
ICD-10 Finland
Other emphysema
273.4
27.4
28
*
J15.8
ICD-10 Finland
Other bacterial pneumonia
41.3
27.2
34
8
EMB10
NOMESCO Finland
Tonsillectomy
7.2
27.2
67
91
R53
ICD-10 Finland
Malaise and fatigue
1.6
26.7
832
5390
A02BC05
ATC
esomeprazole; systemic
1.4
26.7
1912
14687
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
4.1
26.5
105
249
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.5
26.3
96
211
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
33.1
26.0
34
10
L28
ICPC
Limited function/disability (L)
1.6
25.8
770
4933
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
7.1
25.8
64
88
P17
ICPC
Tobacco abuse
5.6
25.8
76
132
C34.34
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or hunga macrocellular anaplastic carcinoma
+∞
25.7
25
*
9051/3-C38.4
ICD-O-3
Fibrous mesothelioma, malignant of pleura, NOS
+∞
25.7
25
*
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
3.6
25.7
119
324
R03AL05
ATC
formoterol and aclidinium bromide; inhalant
35.6
25.7
33
9
N05CD07
ATC
temazepam; oral
1.7
25.5
604
3637
D64.9
ICD-10 Finland
Anaemia, unspecified
1.7
25.2
521
3015
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
10.6
25.1
49
45
R29
ICPC
Respiratory symptom/complaint other
2.2
25.1
253
1115
XG474
NOMESCO Finland
Exhalation nntrogen oxide
6.2
24.9
68
107
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
4.2
24.9
96
223
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.3
24.8
236
1013
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
24.7
576
3454
284
Kela drug reimbursment
Nintedanib and pirfenidone
+∞
24.7
24
*
L01XE36
ATC
[U] alectinib; oral
+∞
24.7
24
*
8041/3-C34.2
ICD-O-3
Small cell carcinoma, NOS, of middle lobe, lung
+∞
24.7
24
*
R03AC19
ATC
olodaterol; inhalant
20.0
24.7
37
18
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
4.5
24.5
89
195
R4190
NOMESCO Finland
Nutritional therapy
2.9
24.3
154
527
J42
ICD-10 Finland
Unspecified chronic bronchitis
9.5
24.3
50
51
5826
FHL
Lobectomy or bilobectomy
126.2
24.3
26
*
J91
ICD-10 Finland
Pleural effusion in conditions classified elsewhere
+∞
23.7
23
*
F17.22
ICD-10 Finland
Addiction-related addiction currently uses controlled substitution treatment
+∞
23.7
23
*
UGC02
NOMESCO Finland
Rigid bronchoscopy
22.0
23.4
34
15
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
18.4
23.4
36
19
WX730
NOMESCO Finland
Conventional respirator
4.7
23.4
80
165
GWE00
NOMESCO Finland
Reoperation for deep haemorrhage in thoracic surgery
84.2
23.3
26
*
J38.4
ICD-10 Finland
Oedema of larynx
121.4
23.3
25
*
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
3.4
23.2
117
342
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.0
23.1
139
460
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
4.2
22.9
88
204
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
3.4
22.9
114
330
J85.2
ICD-10 Finland
Abscess of lung without pneumonia
+∞
22.6
22
*
L01XE16
ATC
[U] crizotinib; oral
+∞
22.6
22
*
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
3.3
22.6
115
339
DQE10
NOMESCO Finland
Injection of foreign material into vocal cord
63.0
22.5
26
*
UGB02
NOMESCO Finland
Tracheoscopy
29.1
22.4
30
10
GA2CT
NOMESCO Finland
Pleural biopsy with CT guidance
223.2
22.3
23
*
J01FA15
ATC
telithromycin; oral
1.9
22.2
366
1966
GDA21
NOMESCO Finland
Thoracoscopic excision of lesion of lung
17.0
22.1
35
20
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
6.1
22.1
61
98
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.8
22.1
148
525
J18
ICD-10 Finland
Pneumonia, organism unspecified
9.1
21.9
46
49
I31.3
ICD-10 Finland
Pericardial effusion (noninflammatory)
10.2
21.8
43
41
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.5
21.7
201
3638
A02BC03
ATC
lansoprazole; oral
1.4
21.7
1367
10197
8250/3-C34.1
ICD-O-3
Lepidic adenocarcinoma of upper lobe, lung
+∞
21.6
21
*
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
+∞
21.6
21
*
8250/3-C34.3
ICD-O-3
Lepidic adenocarcinoma of lower lobe, lung
+∞
21.6
21
*
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.6
21.6
56
83
SFA10
NOMESCO Finland
Fillning on one surface of tooth
0.8
21.6
1709
20079
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
5.7
21.4
62
106
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
3.7
21.4
95
251
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.3
21.4
210
916
GAC46
NOMESCO Finland
Partial decortication of pleura
111.6
21.3
23
*
A01AB09
ATC
miconazole; local oral
1.8
21.3
364
1983
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
21.2
1005
7112
C01AA05
ATC
digoxin; systemic
1.8
21.2
372
2044
J96.9
ICD-10 Finland
Respiratory failure, unspecified
30.2
21.1
28
9
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
20.7
519
3169
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.7
20.6
636
8679
C34.05
ICD-10 Finland
Malignant tumor of the main bronchial other non-microcellular carcinoma
+∞
20.6
20
*
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
4.2
20.5
79
184
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
4.1
20.5
81
194
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.1
20.4
233
1088
R03BB05
ATC
aclidinium bromide; inhalant
36.1
20.4
26
7
D82
ICPC
Teeth/gum disease
0.7
20.3
887
11410
GDC13
NOMESCO Finland
Extended lobectomy or bilobectomy of lung
203.7
20.3
21
*
GD004
NOMESCO Finland
Palliative radiotherapy of trachea, bronchi and lungs
203.7
20.3
21
*
J80
ICD-10 Finland
Adult respiratory distress syndrome
203.7
20.3
21
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.7
20.3
145
535
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
17.7
20.0
31
17
QBC00
NOMESCO Finland
Removal of foreign body from skin of trunk or subcutaneous tissue
21.7
20.0
29
13
XX9XW
NOMESCO Finland
NA
6.0
19.6
54
87
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
6.3
19.6
52
80
D14.3
ICD-10 Finland
Benign neoplasm: Bronchus and lung
11.7
19.5
36
30
J85.1
ICD-10 Finland
Abscess of lung with pneumonia
+∞
19.5
19
*
8010/3-C34.1
ICD-O-3
Carcinoma, NOS, of upper lobe, lung
+∞
19.5
19
*
J86.00
ICD-10 Finland
Empyema with broncho-pleural fistula
+∞
19.5
19
*
GDD20
NOMESCO Finland
Extended pneumonectomy
+∞
19.5
19
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.8
19.5
129
455
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.4
19.4
166
676
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.6
19.4
493
3022
R13
ICD-10 Finland
Dysphagia
1.9
19.3
277
1417
N02AA03
ATC
hydromorphone; systemic, rectal
9.7
19.3
39
39
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.4
19.3
169
698
325
Kela drug reimbursment
Erlotinib
194.0
19.3
20
*
J94.2
ICD-10 Finland
Haemothorax
101.9
19.3
21
*
B02AA02
ATC
tranexamic acid; systemic
1.6
19.2
499
3073
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
3.2
19.2
100
301
SAA02
NOMESCO Finland
Basic examination of mouth
0.8
19.2
2158
24356
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.8
19.1
373
2117
UDQ22
NOMESCO Finland
Microlaryngoscopy
8.0
19.1
43
52
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
19.0
236
1140
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.8
19.0
64
131
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
6.3
18.8
50
77
I87.1
ICD-10 Finland
Compression of vein
15.1
18.8
31
20
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
4.3
18.8
71
163
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
4.0
18.8
76
186
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.8
18.7
120
417
UDM02
NOMESCO Finland
Sinoscopy
5.5
18.6
55
97
GDB20
NOMESCO Finland
Segmental resection of lung
53.4
18.6
22
*
R01AD09
ATC
mometasone; nasal
1.3
18.6
1575
12267
8246/3-C34.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of lung, NOS
+∞
18.5
18
*
8010/3-C34.3
ICD-O-3
Carcinoma, NOS, of lower lobe, lung
+∞
18.5
18
*
GCA02
NOMESCO Finland
Bronchoscopic electrocoagulation of lesion of bronchus
+∞
18.5
18
*
8140/3-C34.0
ICD-O-3
Adenocarcinoma, NOS, of main bronchus
+∞
18.5
18
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
18.5
551
3516
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
3.0
18.5
106
341
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
67.8
18.4
21
*
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.2
18.4
99
306
J98.4
ICD-10 Finland
Other disorders of lung
184.2
18.3
19
*
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
184.2
18.3
19
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.1
18.2
217
1033
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
0.8
18.2
1281
15385
DQA10
NOMESCO Finland
Biopsy of larynx
10.0
18.2
36
35
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.0
18.1
225
1091
PEH56
NOMESCO Finland
Bypass from femoral to popliteal artery above knee
5.1
18.0
57
109
J18.8
ICD-10 Finland
Other pneumonia, organism unspecified
29.1
18.0
24
8
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
18.0
795
5532
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.4
17.9
1095
8087
J01DA06
ATC
[U] cefuroxime; systemic
1.5
17.9
562
3631
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
4.6
17.8
62
132
WX110
NOMESCO Finland
Local anesthesy
1.3
17.7
3271
28211
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
7.9
17.7
40
49
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
4.2
17.7
67
155
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
9.0
17.6
37
40
L01EB01
ATC
gefitinib; oral (epidermal growth factor receptor (egfr) tyrosine kinase inhibitors)
+∞
17.5
17
*
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
+∞
17.5
17
*
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
+∞
17.5
17
*
J12.8
ICD-10 Finland
Other viral pneumonia
64.6
17.4
20
*
N05AA02
ATC
levomepromazine; systemic
2.4
17.4
156
651
WX882
NOMESCO Finland
High dependency care
2.6
17.4
127
475
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.1
17.4
190
873
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.8
17.4
299
1633
WF099
NOMESCO Finland
Other radiotherapy
5.1
17.3
55
106
TXQ05
NOMESCO Finland
Puncture of skin, site unspecified
174.5
17.3
18
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
17.3
894
6408
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
0.6
17.3
255
4080
RS220
NOMESCO Finland
NA
4.2
17.2
65
150
L57.0
ICD-10 Finland
Actinic keratosis
0.6
17.2
273
4294
R60.0
ICD-10 Finland
Localized oedema
1.6
17.1
504
3203
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
16.4
17.0
27
16
B01AC04
ATC
clopidogrel; oral
1.4
17.0
895
6435
SAA01
NOMESCO Finland
Simple examination of mouth
0.8
17.0
2567
28144
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
2.1
16.9
187
863
A01AB04
ATC
amphotericin B; local oral
2.0
16.5
207
1008
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
10.4
16.5
32
30
WX002
NOMESCO Finland
Sedation and analgesia
1.4
16.5
976
7156
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
+∞
16.5
16
*
9699/3-C34.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lung, NOS
+∞
16.5
16
*
9680/3-C34.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lung, NOS
+∞
16.5
16
*
4912A
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]
+∞
16.5
16
*
C34.87
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary carcinoid
+∞
16.5
16
*
9053/3-C38.4
ICD-O-3
Mesothelioma, biphasic, malignant of pleura, NOS
+∞
16.5
16
*
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
+∞
16.5
16
*
356
Kela drug reimbursment
Nintedanib and pirfenidone
+∞
16.5
16
*
N07BB01
ATC
disulfiram; oral
2.2
16.5
169
756
1240
FHL
Bronchoscopy
5.2
16.3
50
93
S27.0
ICD-10 Finland
Traumatic pneumothorax
4.4
16.3
59
131
WX721
NOMESCO Finland
Oxygen concentrator therapy
164.8
16.3
17
*
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.5
16.1
101
2067
A46
ICD-10 Finland
Erysipelas
1.5
16.1
628
4251
N03AX12
ATC
gabapentin; oral
1.5
16.1
650
4433
R82
ICPC
Pleurisy/pleural effusion
38.8
16.1
20
5
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
10.4
16.0
31
29
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.5
15.9
129
514
V03AA01
ATC
NA
3.0
15.9
93
306
J41.0
ICD-10 Finland
Simple chronic bronchitis
12.4
15.8
28
22
4040
NOMESCO Finland
NA
46.0
15.8
19
*
GD6AD
NOMESCO Finland
CT of chest and neck
9.4
15.7
32
33
PD3AT
NOMESCO Finland
Pelvic artery PTA
5.2
15.7
48
89
4402A
ICD-9 Finland
Atherosclerosis, Of native arteries of the extremities
5.0
15.6
50
98
UJC01
NOMESCO Finland
Scopy of lower throat
4.2
15.5
59
138
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.0
15.5
209
1048
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
2.9
15.4
95
322
8046/3-C34.3
ICD-O-3
Non-small cell carcinoma of lower lobe, lung
+∞
15.4
15
*
8140/2-C34.1
ICD-O-3
Adenocarcinoma in situ, NOS, of upper lobe, lung
+∞
15.4
15
*
C45.1
ICD-10 Finland
Mesothelioma of peritoneum
+∞
15.4
15
*
132
Kela drug reimbursment
Sarcoidosis
+∞
15.4
15
*
C34.25
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung other non-microcellular carcinoma
+∞
15.4
15
*
C01DA14
ATC
isosorbide mononitrate; oral
1.4
15.4
772
5491
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
6.8
15.3
38
54
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
4.1
15.3
60
144
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
5.6
15.3
44
76
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.4
15.3
1030
7710
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
18.6
15.2
23
12
PEH57
NOMESCO Finland
Bypass from femoral artery to popliteal artery below knee
4.7
15.2
51
105
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
3.1
15.2
84
266
WX722
NOMESCO Finland
PEEP
2.0
15.2
194
950
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
15.2
1387
10859
R05CB01
ATC
acetylcysteine; inhalant, oral
3.6
15.1
68
184
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
36.9
15.1
19
5
R01AD08
ATC
fluticasone; nasal
1.4
15.1
863
6283
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
10.4
15.1
29
27
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
4.8
15.1
50
102
L15
ICPC
Knee symptom/complaint
0.7
15.0
579
7643
PE1AT
NOMESCO Finland
Femoral artery PTA
3.4
15.0
73
211
K03.64
ICD-10 Finland
Dental calculus supragingival
0.7
15.0
624
8131
30310
ICD-8 Finland
Alcoholism, Habitual excessive drinking
4.5
14.9
52
112
N06DX01
ATC
memantine; oral
0.4
14.9
83
1768
I25.2
ICD-10 Finland
Old myocardial infarction
1.6
14.8
352
2116
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.0
14.8
195
967
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
5.3
14.7
44
80
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.5
14.7
111
426
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
4.4
14.7
53
118
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
3.5
14.7
67
184
SPAT1043
SPAT
Audiometry
0.6
14.7
298
4434
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
14.7
1835
14967
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
14.6
436
2782
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.7
14.6
297
1711
C10AA07
ATC
rosuvastatin; oral
0.7
14.6
877
10822
B03XA02
ATC
darbepoetin alfa; parenteral
3.0
14.5
83
267
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.8
14.4
255
1405
N06AB03
ATC
fluoxetine; oral
1.5
14.4
472
3074
WX734
NOMESCO Finland
JET-ventilation
24.2
14.4
20
8
363
Kela drug reimbursment
Crizotinib
+∞
14.4
14
*
GAC43
NOMESCO Finland
Total decortication of pleura
+∞
14.4
14
*
8240/3-C34.2
ICD-O-3
Neuroendocrine tumor, NOS, of middle lobe, lung
+∞
14.4
14
*
GD002
NOMESCO Finland
Radical radiotherapy of trachea, bronchi and lungs
+∞
14.4
14
*
L04AX05
ATC
pirfenidone; oral
+∞
14.4
14
*
F10.25
ICD-10 Finland
Alcohol dependence continuous use
3.3
14.3
72
214
C38.3
ICD-10 Finland
Malignant neoplasm: Mediastinum, part unspecified
145.4
14.3
15
*
C39.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the respiratory system
145.4
14.3
15
*
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.9
14.2
203
1038
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.1
14.2
79
252
D19
ICPC
Teeth/gum symptom/complaint
0.7
14.2
634
8177
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.0
14.2
180
883
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
10.5
14.1
27
25
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.8
14.1
263
1476
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
3.8
14.1
59
151
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.9
14.1
83
275
E83.50
ICD-10 Finland
Hypercalcemia
3.3
14.1
71
211
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.8
14.1
246
1351
N07BC02
ATC
methadone; systemic
9.1
14.1
29
31
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
3.0
14.0
82
271
SPAT1111
SPAT
Planning of analgesia
3.6
14.0
62
167
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
0.6
13.9
193
3140
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
6.7
13.9
35
51
GBB00
NOMESCO Finland
Tracheostomy
4.0
13.8
54
130
R03DC01
ATC
zafirlukast; oral
4.4
13.8
49
108
A02BA04
ATC
nizatidine; systemic
1.6
13.8
356
2191
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.7
13.7
270
1541
N05AH04
ATC
quetiapine; oral
1.5
13.7
487
3233
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
4.4
13.6
49
109
SDA02
NOMESCO Finland
Parodonthologic therapy
0.8
13.6
952
11523
ZX100
NOMESCO Finland
Oral
3.0
13.5
78
254
GDA20
NOMESCO Finland
Excision of lesion of lung
17.0
13.5
21
12
A04AA03
ATC
tropisetron; systemic
6.1
13.5
36
57
D70.89
ICD-10 Finland
Neutropenic splenomegaly
3.7
13.5
58
152
RS222
NOMESCO Finland
NA
3.5
13.5
62
172
BC1CD
NOMESCO Finland
Very extensive CT of adrenal glands
6.6
13.5
34
50
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.2
13.4
71
219
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
5.7
13.4
38
65
A96
ICPC
Death
6.3
13.4
35
54
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.7
13.4
294
1731
GAC37
NOMESCO Finland
Endoscopic chemical pleurodesis
72.8
13.4
15
*
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
72.8
13.4
15
*
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.6
13.4
336
2052
C34.04
ICD-10 Finland
Malignant tumor of the main bronchial macrocellular anaplastic carcinoma
+∞
13.4
13
*
C34.84
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary macrocellular anaplastic carcinoma
+∞
13.4
13
*
J86.09
ICD-10 Finland
Pyothorax with fistula
+∞
13.4
13
*
8480/3-C34.1
ICD-O-3
Mucinous adenocarcinoma of upper lobe, lung
+∞
13.4
13
*
8013/3-C34.1
ICD-O-3
Large cell neuroendocrine carcinoma of upper lobe, lung
+∞
13.4
13
*
8020/3-C34.9
ICD-O-3
Carcinoma, undifferentiated, NOS, of lung, NOS
+∞
13.4
13
*
8249/3-C34.3
ICD-O-3
Neuroendocrine tumor, grade 2 of lower lobe, lung
+∞
13.4
13
*
L01CE01
ATC
topotecan; systemic
+∞
13.4
13
*
TGA10
NOMESCO Finland
Needle biopsy of pleura
+∞
13.4
13
*
N05AB01
ATC
dixyrazine; systemic
3.2
13.3
68
205
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
33.0
13.3
17
5
C03DA01
ATC
spironolactone; oral
1.5
13.3
460
3036
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
3.3
13.3
66
195
HA1AA
NOMESCO Finland
X-ray mammography
1.7
13.2
304
1812
Z02.4
ICD-10 Finland
Examination for driving licence
0.8
13.2
1126
13307
ZYC01
SPAT
NA
0.4
13.2
55
1301
Z51.0
ICD-10 Finland
Radiotherapy session
2.8
13.2
84
294
M04AA01
ATC
allopurinol; systemic
1.4
13.1
638
4504
30300
ICD-8 Finland
Alcoholism, Episodic excessive drinking
3.4
13.1
63
181
A04
ICPC
Weakness/tiredness general
1.5
13.1
484
3238
SPAT1062
SPAT
Lung clearance therapy
9.0
13.1
27
29
N05BA02
ATC
chlordiazepoxide; systemic
2.4
13.1
113
466
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.3
13.1
119
505
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
13.1
1092
8419
WX704
NOMESCO Finland
Intubation
1.6
13.0
306
1837
N05AH02
ATC
clozapine; systemic
4.6
12.9
44
93
C38.1
ICD-10 Finland
Malignant neoplasm: Anterior mediastinum
38.7
12.9
16
*
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
3.8
12.9
53
134
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.8
12.9
223
1221
SDA01
NOMESCO Finland
Simple parodonthologic therapy
0.7
12.9
604
7746
K59.09
ICD-10 Finland
Constipation, unspecified
1.7
12.9
267
1548
TK800
NOMESCO Finland
Hemodialysis
2.7
12.8
84
299
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.1
12.7
137
627
J32.4
ICD-10 Finland
Chronic pansinusitis
27.5
12.7
17
6
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
3.8
12.6
52
132
N03AF01
ATC
carbamazepine; oral, rectal
1.8
12.6
209
1131
J34.8
ICD-10 Finland
Other specified disorders of nose and nasal sinuses
11.2
12.5
23
20
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
11.2
12.5
23
20
SPAT1053
SPAT
Memory test
0.7
12.4
562
7250
R2110
NOMESCO Finland
Giving the first information
1.7
12.4
252
1454
JN5AP
NOMESCO Finland
Total body PET (1 picture)
31.0
12.3
16
5
8550/3-C34.1
ICD-O-3
Acinar cell carcinoma of upper lobe, lung
+∞
12.3
12
*
A15.1
ICD-10 Finland
Tuberculosis of lung, confirmed by culture only
+∞
12.3
12
*
GAC30
NOMESCO Finland
Artificial pneumothorax
+∞
12.3
12
*
C34.07
ICD-10 Finland
Malignant tumor of the main bronchus carcinoid
+∞
12.3
12
*
8249/3-C34.1
ICD-O-3
Neuroendocrine tumor, grade 2 of upper lobe, lung
+∞
12.3
12
*
XGX10
NOMESCO Finland
Intrapleural ultrasonography
+∞
12.3
12
*
L01XE31
ATC
[U] nintedanib; oral
+∞
12.3
12
*
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
+∞
12.3
12
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
2.6
12.3
86
318
L04AA06
ATC
mycophenolic acid; systemic
3.6
12.3
54
145
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
3.6
12.3
55
150
F17.2
ICD-10 Finland
Mental and behavioural disorders due to use of tobacco, dependence syndrome
5.8
12.3
34
57
C39.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of respiratory and intrathoracic organs
126.0
12.3
13
*
30320
ICD-8 Finland
Alcoholism, Alcoholic addiction
4.0
12.2
48
117
SPAT1276
SPAT
Outlining of treatment with patient or their family members
2.3
12.2
108
453
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.3
12.2
1197
9425
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
1.7
12.1
249
1440
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
6.1
12.0
32
51
XQ800
NOMESCO Finland
Prick test
2.0
12.0
153
754
ZX108
NOMESCO Finland
Inhalation
6.6
12.0
30
44
E87.6
ICD-10 Finland
Hypokalaemia
2.1
12.0
134
625
XW000
NOMESCO Finland
Bone marrow biopsy
1.9
11.9
178
929
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
2.2
11.9
116
509
J01DA08
ATC
[U] cefaclor; oral
1.6
11.9
282
1698
N06DA02
ATC
donepezil; oral
0.5
11.9
86
1677
Z01.2
ICD-10 Finland
Dental examination
0.8
11.8
1229
14223
R4130
NOMESCO Finland
Speech therapy
2.5
11.8
91
356
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
12.0
11.8
21
17
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
12.0
11.8
21
17
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
0.6
11.8
140
2365
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.6
11.7
85
319
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
1.9
11.7
165
842
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.5
11.7
79
1578
SPAT1060
SPAT
Administration of oxygen
7.9
11.7
26
32
WZA10
NOMESCO Finland
Long statement of health and health related matters
3.2
11.7
59
177
P01BA02
ATC
hydroxychloroquine; oral
1.6
11.6
305
1887
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.2
11.6
114
502
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
3.8
11.5
47
119
OAA67
SPAT
NA
0.3
11.5
27
818
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
3.1
11.5
61
190
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
2.4
11.5
94
379
GAA97
NOMESCO Finland
Other thoracoscopic drainage procedures on pleura
29.1
11.4
15
5
GAC96
NOMESCO Finland
Other operation on pleura
62.9
11.4
13
*
GAC47
NOMESCO Finland
Endoscopic partial decortication of pleura
62.9
11.4
13
*
1XC18
NOMESCO Finland
NA
62.9
11.4
13
*
SPAT1104
SPAT
Monitoring of emergency patient
1.6
11.4
301
1866
J01FA10
ATC
azithromycin; systemic
1.2
11.4
2178
18498
GDA96
NOMESCO Finland
Other incision, excision of lesion or repair of lung
+∞
11.3
11
*
8013/3-C34.9
ICD-O-3
Large cell neuroendocrine carcinoma of lung, NOS
+∞
11.3
11
*
8480/3-C34.9
ICD-O-3
Mucinous adenocarcinoma of lung, NOS
+∞
11.3
11
*
GDD96
NOMESCO Finland
Other pneumonectomy
+∞
11.3
11
*
8230/3-C34.1
ICD-O-3
Solid carcinoma, NOS, of upper lobe, lung
+∞
11.3
11
*
C34.93
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary bronchoalveolar carcinoma
+∞
11.3
11
*
GA3CT
NOMESCO Finland
Pleural cytology with CT guidance
+∞
11.3
11
*
B90.9
ICD-10 Finland
Sequelae of respiratory and unspecified tuberculosis
+∞
11.3
11
*
8012/3-C34.1
ICD-O-3
Large cell carcinoma, NOS, of upper lobe, lung
+∞
11.3
11
*
01102
ICD-8 Finland
Pulmonary tuberculosis, Non cavernosa
+∞
11.3
11
*
8000/1-C34.9
ICD-O-3
Neoplasm, uncertain whether benign or malignant of lung, NOS
+∞
11.3
11
*
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.6
11.3
308
1924
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
116.3
11.3
12
*
GAC36
NOMESCO Finland
Chemical pleurodesis
116.3
11.3
12
*
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
11.2
1161
9196
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
11.2
682
5007
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
0.7
11.1
631
7880
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
2.2
11.1
113
505
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
3.9
11.1
44
109
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.0
11.1
135
655
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
11.1
502
3496
GWW96
NOMESCO Finland
Other reoperation in thoracic surgery
33.9
11.1
14
*
J35.1
ICD-10 Finland
Hypertrophy of tonsils
33.9
11.1
14
*
F17.1
ICD-10 Finland
Mental and behavioural disorders due to use of tobacco, harmful use
33.9
11.1
14
*
G20
ICD-10 Finland
Parkinson disease
0.4
11.0
36
937
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
11.0
1230
9825
L82
ICD-10 Finland
Seborrhoeic keratosis
0.7
11.0
473
6153
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.5
11.0
385
2548
JN4DD
NOMESCO Finland
Scout CT scan of torso
6.7
11.0
27
39
PDH54
NOMESCO Finland
Bypass from aorta to bilateral femoral arteries
10.2
11.0
21
20
I50.1
ICD-10 Finland
Left ventricular failure
1.8
11.0
180
970
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.7
10.9
235
1379
JN5KR
NOMESCO Finland
Very extensive PET-CT of upper body metabolism (eyebrows to thighs)
19.4
10.9
16
8
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
2.5
10.9
81
312
B01AA03
ATC
warfarin; systemic
1.3
10.8
969
7531
N40
ICD-10 Finland
Hyperplasia of prostate
0.8
10.7
982
11550
R04.9
ICD-10 Finland
Haemorrhage from respiratory passages, unspecified
8.9
10.7
22
24
S72.0
ICD-10 Finland
Fracture of neck of femur
1.9
10.7
151
775
N06AA12
ATC
doxepin; systemic
1.7
10.7
226
1321
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.7
10.7
356
4829
R49.08
ICD-10 Finland
Other specified dysphonia
2.8
10.7
65
223
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
2.9
10.6
62
206
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.5
10.6
376
2495
C32.1
ICD-10 Finland
Malignant neoplasm: Supraglottis
11.5
10.6
19
16
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.7
10.5
445
5803
TJD20
NOMESCO Finland
Change of gastrostomy tube
8.0
10.5
23
28
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
0.8
10.5
1411
15924
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
2.4
10.5
90
372
R03BB02
ATC
oxitropium bromide; inhalant
8.5
10.5
22
25
PD3BT
NOMESCO Finland
Pelvic artery extensive PTA
8.5
10.5
22
25
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
10.4
1749
14615
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.9
10.4
61
204
1CD02
NOMESCO Finland
NA
3.6
10.4
45
121
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
0.4
10.3
49
1103
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
10.3
1759
14723
8140/3-C34.8
ICD-O-3
Adenocarcinoma, NOS, of overlapping lesion of lung
+∞
10.3
10
*
C45
ICD-10 Finland
Mesothelioma
+∞
10.3
10
*
8560/3-C34.3
ICD-O-3
Adenosquamous carcinoma of lower lobe, lung
+∞
10.3
10
*
F17.3
ICD-10 Finland
Mental and behavioural disorders due to use of tobacco, withdrawal state
+∞
10.3
10
*
J39.0
ICD-10 Finland
Retropharyngeal and parapharyngeal abscess
+∞
10.3
10
*
8246/3-C34.1
ICD-O-3
Neuroendocrine carcinoma, NOS, of upper lobe, lung
+∞
10.3
10
*
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
+∞
10.3
10
*
FEB10
NOMESCO Finland
Decompression and drainage of pericardium
6.1
10.3
27
43
GBA35
NOMESCO Finland
Endoscopic insertion of stent into trachea
106.6
10.3
11
*
GEB40
NOMESCO Finland
Mediastinotomy and extended excision of lesion
106.6
10.3
11
*
J43.1
ICD-10 Finland
Panlobular emphysema
106.6
10.3
11
*
K08.3
ICD-10 Finland
Retained dental root
1.5
10.2
302
1926
H02
ICPC
Hearing complaint
0.7
10.1
391
5174
ZX114
NOMESCO Finland
Intramuscular
2.9
10.1
60
203
R52.2
ICD-10 Finland
Other chronic pain
2.0
10.1
118
563
PE1YT
NOMESCO Finland
Femoral or popliteal artery PTA with stent
3.0
10.0
55
177
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
3.0
10.0
55
177
N06AA09
ATC
amitriptyline; systemic
1.5
10.0
387
2617
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
3.4
10.0
46
130
JN3AD
NOMESCO Finland
Abdominal CT examination
1.5
10.0
313
2024
H02AB09
ATC
hydrocortisone; systemic
2.5
10.0
74
283
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.7
10.0
195
1116
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
3.8
10.0
40
101
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
3.3
9.9
49
146
VALMI
NOMESCO Finland
NA
0.8
9.9
584
7263
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.4
9.9
453
3167
P20
ICPC
Memory disturbance
0.7
9.9
367
4887
SPAT1290
SPAT
Preparation of deceased person
7.6
9.8
22
28
GD3CT
NOMESCO Finland
Labeling lungs with CT guidance
38.7
9.8
12
*
WX726
NOMESCO Finland
High-flow oxygen therapy
38.7
9.8
12
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.4
9.8
460
3226
GX1K5
NOMESCO Finland
Diffusion capacity
14.1
9.8
16
11
R60.9
ICD-10 Finland
Oedema, unspecified
1.7
9.8
188
1071
N06AX16
ATC
venlafaxine; oral
1.4
9.8
398
2718
OAB42
SPAT
NA
0.5
9.7
56
1176
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.2
9.7
93
407
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
3.1
9.6
50
155
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
2.7
9.6
62
221
L90
ICPC
Osteoarthrosis of knee
0.6
9.6
133
2161
M05BA04
ATC
alendronic acid; oral
1.5
9.6
338
2240
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
19.4
9.6
14
7
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.8
9.6
1009
11702
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.2
9.5
1260
10248
PD5BD
NOMESCO Finland
Extensive CT of aorta
2.1
9.5
100
458
R92
ICPC
Neoplasm respiratory unspecified
53.3
9.5
11
*
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
1.9
9.5
137
711
R01AD11
ATC
triamcinolone; nasal
1.6
9.5
251
1560
OAB43
SPAT
NA
0.5
9.5
91
1628
H13
ICPC
Plugged feeling ear
0.8
9.5
635
7769
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
12.9
9.5
16
12
I42.0
ICD-10 Finland
Dilated cardiomyopathy
2.0
9.4
118
581
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
3.8
9.4
38
97
R99
ICPC
Respiratory disease other
2.6
9.4
67
252
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
2.6
9.4
67
252
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
0.8
9.4
766
9143
D07AA02
ATC
hydrocortisone; topical
1.4
9.3
443
3111
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
5.6
9.3
26
45
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
2.6
9.3
64
237
M01AX05
ATC
glucosamine; oral
0.8
9.3
741
8876
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
2.0
9.3
117
578
N06DA03
ATC
rivastigmine; oral, transdermal
0.4
9.3
40
932
K92.1
ICD-10 Finland
Melaena
1.6
9.3
228
1391
1623C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,ADENOCARCINOMA]
+∞
9.3
9
*
C34.94
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary macrocellular anaplastic carcinoma
+∞
9.3
9
*
8000/3-C38.4
ICD-O-3
Neoplasm, malignant of pleura, NOS
+∞
9.3
9
*
8013/3-C34.3
ICD-O-3
Large cell neuroendocrine carcinoma of lower lobe, lung
+∞
9.3
9
*
1623A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA EPIDERMOIDES]
+∞
9.3
9
*
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
+∞
9.3
9
*
8550/3-C34.3
ICD-O-3
Acinar cell carcinoma of lower lobe, lung
+∞
9.3
9
*
J84.0
ICD-10 Finland
Alveolar and parietoalveolar conditions
+∞
9.3
9
*
Z94.2
ICD-10 Finland
Lung transplant status
+∞
9.3
9
*
8020/3-C34.1
ICD-O-3
Carcinoma, undifferentiated, NOS, of upper lobe, lung
+∞
9.3
9
*
P16
ICPC
Acute alcohol abuse
2.9
9.2
55
187
C76.1
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Thorax
29.1
9.2
12
*
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
1.9
9.2
136
709
I74.3
ICD-10 Finland
Embolism and thrombosis of arteries of lower extremities
3.1
9.1
49
156
N05BA12
ATC
alprazolam; oral
1.4
9.1
380
2608
A07AA09
ATC
vancomycin; oral
3.1
9.1
47
146
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.0
9.1
117
583
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.4
9.0
409
2848
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
4.0
9.0
35
86
N06AB10
ATC
escitalopram; oral
1.3
9.0
566
4170
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
0.4
9.0
45
990
R03DA54
ATC
theophylline, combinations excl. psycholeptics; systemic
3.3
9.0
44
131
ZX112
NOMESCO Finland
Subcutaneous
2.1
9.0
94
430
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
3.7
9.0
37
96
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.7
9.0
177
1016
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
3.7
9.0
38
101
H40.0
ICD-10 Finland
Glaucoma suspect
0.6
9.0
186
2759
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.7
9.0
395
5124
I73.9
ICD-10 Finland
Peripheral vascular disease, unspecified
3.1
9.0
46
142
WX872
NOMESCO Finland
Intensive care
1.6
9.0
225
1380
HMAK
NOMESCO Finland
NA
0.7
8.9
237
3349
F10.24
ICD-10 Finland
Alcohol depence active use
2.9
8.9
52
174
F10.20
ICD-10 Finland
Alcohol dependence currently independent
2.5
8.9
69
274
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
2.7
8.9
58
209
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
4.4
8.9
31
69
N05AF03
ATC
chlorprothixene; systemic
2.2
8.9
83
361
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
3.5
8.9
39
107
WGA11
NOMESCO Finland
Planning of pain management
7.5
8.9
20
26
DMB10
NOMESCO Finland
Radical maxillary antrotomy
35.5
8.9
11
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.0
8.9
115
572
1DC02
NOMESCO Finland
NA
6.5
8.9
22
33
E000001
ATC
NA
1.3
8.9
736
5651
N04BD01
ATC
selegiline; oral
0.2
8.8
6
363
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
0.8
8.8
758
8997
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
1.9
8.8
131
688
L04AD01
ATC
ciclosporin; systemic
2.6
8.8
60
222
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
4.1
8.7
32
75
J01DC02
ATC
cefuroxime; systemic
1.7
8.7
165
936
I20.90
ICD-10 Finland
Angina pectoris, unspecified
1.7
8.6
163
922
J01FA01
ATC
erythromycin; systemic
1.4
8.6
398
2782
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
4.1
8.6
32
76
R03AK
ATC
Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
7.7
8.6
19
24
L13
ICPC
Hip symptom/complaint
0.8
8.6
478
5992
S01ED51
ATC
timolol, combinations; ophthalmic
0.7
8.6
215
3070
WE198
NOMESCO Finland
Palliative cystotatic therapy
8.3
8.6
18
21
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.0
8.6
49
161
C43.12
ICD-10 Finland
Malignant melanoma of eyelids including corner of eye: 'superficial spreading' type
48.4
8.5
10
*
GDA97
NOMESCO Finland
Other thoracoscopic incision, excision of lesion or repair of lung
48.4
8.5
10
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.0
8.5
47
153
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
4.6
8.5
28
59
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
2.8
8.4
52
182
I95.9
ICD-10 Finland
Hypotension, unspecified
2.6
8.4
58
215
R51.80
ICD-10 Finland
Headache
1.4
8.4
416
2950
5188X
ICD-9 Finland
Other diseases of lung
15.7
8.4
13
8
B01AF01
ATC
rivaroxaban; oral
0.7
8.4
384
4950
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
2.2
8.4
84
377
I26
ICD-10 Finland
Pulmonary embolism
3.1
8.4
44
139
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.8
8.4
684
8170
N06AX21
ATC
duloxetine; oral
1.5
8.3
322
2177
F2680
NOMESCO Finland
NA
26.6
8.3
11
*
J98.9
ICD-10 Finland
Respiratory disorder, unspecified
26.6
8.3
11
*
GX2C5
NOMESCO Finland
Short-lasting oximetry
26.6
8.3
11
*
J98.2
ICD-10 Finland
Interstitial emphysema
87.2
8.3
9
*
J10.8
ICD-10 Finland
Influenza with other manifestations, seasonal influenza virus identified
87.2
8.3
9
*
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
0.5
8.3
47
988
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.2
8.3
955
7636
EB1AA
NOMESCO Finland
Tooth X-ray examination
0.8
8.3
1975
21277
1XC02
NOMESCO Finland
NA
3.5
8.2
36
99
8000/3-C34.0
ICD-O-3
Neoplasm, malignant of main bronchus
+∞
8.2
8
*
8260/3-C34.1
ICD-O-3
Papillary adenocarcinoma, NOS, of upper lobe, lung
+∞
8.2
8
*
8071/3-C34.1
ICD-O-3
Squamous cell carcinoma, keratinizing, NOS, of upper lobe, lung
+∞
8.2
8
*
1625X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,EI HIST/SYTOL DG]
+∞
8.2
8
*
L01ED01
ATC
crizotinib; oral
+∞
8.2
8
*
8000/3-C34.2
ICD-O-3
Neoplasm, malignant of middle lobe, lung
+∞
8.2
8
*
GD003
NOMESCO Finland
Adjuvant radiotherapy of trachea, bronchi and lungs
+∞
8.2
8
*
C34.23
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung bronchoalveolar carcinoma
+∞
8.2
8
*
J05.1
ICD-10 Finland
Acute epiglottitis
+∞
8.2
8
*
A16.0
ICD-10 Finland
Tuberculosis of lung, bacteriologically and histologically negative
+∞
8.2
8
*
8020/3-C34.3
ICD-O-3
Carcinoma, undifferentiated, NOS, of lower lobe, lung
+∞
8.2
8
*
J70.1
ICD-10 Finland
Chronic and other pulmonary manifestations due to radiation
+∞
8.2
8
*
9591/3-C34.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lung, NOS
+∞
8.2
8
*
GAC10
NOMESCO Finland
Removal of foreign body from pleural cavity
+∞
8.2
8
*
FE1AE
NOMESCO Finland
Pericardial ultrasound examination
+∞
8.2
8
*
J70.4
ICD-10 Finland
Drug-induced interstitial lung disorders, unspecified
+∞
8.2
8
*
8560/3-C34.1
ICD-O-3
Adenosquamous carcinoma of upper lobe, lung
+∞
8.2
8
*
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
2.3
8.2
70
292
DAX08
NOMESCO Finland
Fitting of hearing aid
0.5
8.2
85
1486
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
2.2
8.2
76
331
P15
ICPC
Chronic alcohol abuse
2.1
8.2
88
408
GD2SN
NOMESCO Finland
Lung ventilation SPECT
4.8
8.2
26
53
R52.9
ICD-10 Finland
Pain, unspecified
1.5
8.2
310
2089
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
5.8
8.2
22
37
WX707
NOMESCO Finland
Fiberoscopic intubation
5.8
8.2
22
37
UJD02
NOMESCO Finland
Gastroscopy
1.6
8.2
191
1152
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.5
8.2
284
1882
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.4
8.2
64
257
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
7.6
8.1
18
23
G04BD12
ATC
mirabegron; oral
0.7
8.1
294
3931
R07.3
ICD-10 Finland
Other chest pain
1.4
8.1
358
2486
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.7
8.1
158
904
G81.9
ICD-10 Finland
Hemiplegia, unspecified
3.2
8.1
40
121
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
2.4
8.1
63
251
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
3.8
8.1
32
81
R01
ICPC
Pain respiratory system
2.9
8.1
47
158
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.6
8.1
215
1338
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.3
8.0
612
4638
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.2
8.0
1166
9562
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.5
8.0
282
1875
V03AB30
ATC
NA
3.0
8.0
43
139
DPA30
NOMESCO Finland
Sphenotomy
32.3
7.9
10
*
J02AC01
ATC
fluconazole; systemic
1.2
7.9
1324
11008
JD1EE
NOMESCO Finland
Ultrasound examination of gastro-oesophageal reflux
6.3
7.9
20
31
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
7.3
7.9
18
24
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
0.7
7.9
273
3684
PEN23
NOMESCO Finland
Plastic repair of femoral artery
2.8
7.9
47
161
TGW99
NOMESCO Finland
Other minor procedure in thoracic surgery
16.6
7.9
12
7
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
3.1
7.9
41
129
49300
ICD-8 Finland
Asthma, bronchiale
2.5
7.9
58
224
F1246
NOMESCO Finland
NA
21.3
7.9
11
5
J43
ICD-10 Finland
Emphysema
21.3
7.9
11
5
M16.1
ICD-10 Finland
Other primary coxarthrosis
0.7
7.8
357
4607
SPAT1312
SPAT
General health counselling
0.8
7.8
1103
12453
C61
ICD-10 Finland
Malignant neoplasm of prostate
0.7
7.8
380
4858
K86
ICPC
Hypertension uncomplicated
0.7
7.8
407
5153
WNF00
NOMESCO Finland
Infection source and contact determination
6.1
7.8
20
32
K92.0
ICD-10 Finland
Haematemesis
2.0
7.8
92
446
ZXC10
NOMESCO Finland
Use of laser
2.0
7.8
92
446
5BA08
NOMESCO Finland
NA
4.3
7.7
27
61
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
0.6
7.7
89
1509
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
2.3
7.7
69
294
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
5.3
7.7
22
40
R4120
NOMESCO Finland
Occupational therapy
1.5
7.7
246
1601
S82
ICPC
Naevus/mole
0.7
7.7
318
4161
F20.9
ICD-10 Finland
Schizophrenia, unspecified
2.5
7.6
54
206
J32.1
ICD-10 Finland
Chronic frontal sinusitis
43.5
7.6
9
*
C79.41
ICD-10 Finland
Secondary malignant tumor of optic nerve and eye
43.5
7.6
9
*
J98.6
ICD-10 Finland
Disorders of diaphragm
43.5
7.6
9
*
PD4CM
NOMESCO Finland
Extensive MRI examination of abdominal aorta and vasculature of lower extremities with 3 Tesla magnet
5.2
7.6
22
41
RS230
NOMESCO Finland
NA
5.2
7.6
22
41
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
1.7
7.6
141
800
C10AX09
ATC
ezetimibe; oral
0.7
7.6
336
4355
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
1.6
7.5
184
1123
29580
ICD-8 Finland
Schizophrenia, Other
3.8
7.5
30
77
F10.09
ICD-10 Finland
Alcohol intoxication UNS
2.3
7.5
65
275
XX7LW
NOMESCO Finland
NA
7.2
7.5
17
23
L30.3
ICD-10 Finland
Infective dermatitis
1.8
7.5
129
714
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
2.9
7.4
43
144
J81
ICD-10 Finland
Pulmonary oedema
24.2
7.4
10
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
2.2
7.4
70
307
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.4
7.4
299
2043
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.3
7.4
500
3722
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
3.4
7.4
34
98
SPAT1229
SPAT
Assessment of need for aid
1.4
7.4
333
2319
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
7.4
682
5308
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.6
7.4
163
970
I82.80
ICD-10 Finland
Emboli and thrombosis in the subclavian vein
9.7
7.3
14
14
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.4
7.3
295
2014
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
0.4
7.3
39
837
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
2.1
7.3
75
343
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
0.7
7.3
218
3016
K80
ICPC
Cardiac arrhythmia NOS
0.7
7.3
166
2412
ZXA10
NOMESCO Finland
Bilateral
1.3
7.3
799
6342
GD1UN
NOMESCO Finland
Lung circulation SPECT
4.7
7.3
23
47
L01EB02
ATC
erlotinib; oral (epidermal growth factor receptor (egfr) tyrosine kinase inhibitors)
77.5
7.3
8
*
RS224
NOMESCO Finland
NA
5.9
7.3
19
31
64091
ICD-8 Finland
Medical termination of pregnancy, Weakness (medical-social reason)
1.6
7.3
159
944
8140/3-C80.9
ICD-O-3
Adenocarcinoma, NOS, of unknown primary site
6.9
7.3
17
24
127
Kela drug reimbursment
Transplant complication
2.9
7.3
42
141
B01AC07
ATC
dipyridamole; systemic
1.6
7.3
178
1088
G56.2
ICD-10 Finland
Lesion of ulnar nerve
1.8
7.3
118
641
PD1AE
NOMESCO Finland
Ultrasound examination of abdominal aortta
3.0
7.3
38
121
9128
FHL
Open reduction and osteosynthesis
1.8
7.2
112
598
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.5
7.2
233
1520
UJC12
NOMESCO Finland
Flexible oesophagoscopy
3.4
7.2
33
95
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
4.1
7.2
26
61
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.4
7.2
380
2724
8010/3-C34.2
ICD-O-3
Carcinoma, NOS, of middle lobe, lung
+∞
7.2
7
*
51899
ICD-8 Finland
Bronchiectasis
+∞
7.2
7
*
C34.83
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary bronchoalveolar carcinoma
+∞
7.2
7
*
8070/3-C34.8
ICD-O-3
Squamous cell carcinoma, NOS, of overlapping lesion of lung
+∞
7.2
7
*
GCA18
NOMESCO Finland
Bronchoscopic dilatation of bronchus
+∞
7.2
7
*
C34.03
ICD-10 Finland
Malignant tumor of the main bronchial bronchoalveolar carcinoma
+∞
7.2
7
*
GDB01
NOMESCO Finland
Thoracoscopic resection of bullae of lung
+∞
7.2
7
*
01220
ICD-8 Finland
Other respiratory tuberculosis, Pleurisy with effusion without mention of cause
+∞
7.2
7
*
8072/3-C34.1
ICD-O-3
Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of upper lobe, lung
+∞
7.2
7
*
49104
ICD-8 Finland
Chronic bronchitis, Cum emphysemate
+∞
7.2
7
*
13599
ICD-8 Finland
Sarcoidosis, Unspecified
+∞
7.2
7
*
16214
ICD-8 Finland
Malignant neoplasm of trachea, bronchus and lung, Lobi inferioris pulmonis
+∞
7.2
7
*
3017
Kela drug reimbursment
Brigatinib
+∞
7.2
7
*
16212
ICD-8 Finland
Malignant neoplasm of trachea, bronchus and lung, Lobi superioris pulmonis
+∞
7.2
7
*
J94.0
ICD-10 Finland
Chylous effusion
+∞
7.2
7
*
DQE20
NOMESCO Finland
Implantation of foreign material in vocal chord
+∞
7.2
7
*
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
+∞
7.2
7
*
4940A
ICD-9 Finland
Bronchiectasis[BRONCHIECTASIAE]
+∞
7.2
7
*
8072/3-C34.3
ICD-O-3
Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of lower lobe, lung
+∞
7.2
7
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
2.2
7.2
68
299
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
5.8
7.1
19
32
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
0.8
7.1
602
7173
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
10.5
7.1
13
12
S12
ICPC
Insect bite/sting
0.7
7.1
206
2862
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.9
7.1
41
137
N05AH03
ATC
olanzapine; systemic
1.7
7.1
145
844
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
0.8
7.1
672
7908
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.7
7.1
362
4598
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.4
7.1
369
2641
RS123
NOMESCO Finland
NA
15.2
7.1
11
7
4760A
ICD-9 Finland
Chronic laryngitis and laryngotracheitis, Chronic laryngitis
6.6
7.1
17
25
PEF24
NOMESCO Finland
Thrombendarterectomy of deep femoral artery
3.9
7.1
27
67
D01BA02
ATC
terbinafine; oral; topical
0.8
7.1
909
10365
M01AH05
ATC
etoricoxib; oral
0.9
7.1
2259
23887
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.4
7.1
305
2112
R78
ICPC
Acute bronchitis/bronchiolitis
2.2
7.0
65
284
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
1.8
7.0
122
679
A10BK03
ATC
empagliflozin; oral
0.7
7.0
161
2334
J16.8
ICD-10 Finland
Pneumonia due to other specified infectious organisms
29.0
7.0
9
*
SPAT1056
SPAT
Pleural puncture
29.0
7.0
9
*
AN1
HP
Coronary angiography
1.3
7.0
589
4525
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
6.0
7.0
18
29
J01MA02
ATC
ciprofloxacin; systemic
1.2
7.0
1774
15284
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
2.8
7.0
42
146
K20
ICD-10 Finland
Oesophagitis
2.2
7.0
67
297
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.1
7.0
77
364
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
3.9
7.0
27
68
R05DB20
ATC
other cough suppressants - combinations
1.6
7.0
178
1101
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.5
7.0
212
1368
XX1AD
NOMESCO Finland
Other CT-examination
2.9
6.9
40
134
1420
FHL
Laryngomicroscopy
3.1
6.9
35
109
R05CB03
ATC
carbocisteine; oral
2.0
6.9
81
392
PD4CC
NOMESCO Finland
Very extensive arterigography of lower extremity with X-ray
3.0
6.9
37
120
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
7.6
6.9
15
19
5BX04
NOMESCO Finland
NA
7.6
6.9
15
19
R05DB05
ATC
pentoxyverine; oral, rectal
1.7
6.9
138
798
A69.2
ICD-10 Finland
Lyme disease
0.6
6.9
96
1550
C79.0
ICD-10 Finland
Secondary malignant neoplasm of kidney and renal pelvis
9.7
6.9
13
13
N05BB01
ATC
hydroxyzine; systemic
1.6
6.9
191
1205
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
1.7
6.9
134
769
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
2.1
6.9
69
314
K29.3
ICD-10 Finland
Chronic superficial gastritis
1.7
6.9
129
735
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
3.1
6.9
35
110
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
5.4
6.8
19
34
RL210
NOMESCO Finland
NA
5.4
6.8
19
34
SPD00
NOMESCO Finland
Fitting and preparation of total teeth prosthesis
2.3
6.8
58
244
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
0.7
6.8
208
2860
A02BA03
ATC
famotidine; systemic
1.6
6.8
154
923
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
6.7
6.8
16
23
A10BK01
ATC
dapagliflozin; oral
0.6
6.8
75
1286
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
2.1
6.8
75
353
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
2.8
6.8
41
144
G44.0
ICD-10 Finland
Cluster headache syndrome
3.4
6.8
30
85
PEF25
NOMESCO Finland
Thrombendarterectomy of superficial femoral artery
3.4
6.8
30
85
RK110
NOMESCO Finland
NA
3.4
6.8
30
85
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.8
6.8
40
138
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
0.7
6.8
166
2375
S97
ICPC
Chronic ulcer skin
1.5
6.7
205
1322
KA1AE
NOMESCO Finland
Kidney ultrasound examination
1.8
6.7
102
541
SGB30
NOMESCO Finland
Other demanding filling of root channel of tooth
0.7
6.7
153
2222
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
2.0
6.7
82
404
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
6.1
6.7
17
27
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.2
6.7
65
290
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.4
6.7
370
2675
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
2.8
6.7
40
139
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
5.0
6.7
20
39
PJA10
NOMESCO Finland
Exploration of lymph nodes
2.4
6.7
54
221
PDP20
NOMESCO Finland
Percutaneous plastic repair of common iliac artery
5.6
6.7
18
31
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
5.6
6.7
18
31
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.3
6.7
568
4369
J20.0
ICD-10 Finland
Acute bronchitis due to Mycoplasma pneumoniae
5.3
6.7
19
35
ZXF05
NOMESCO Finland
Interruption of procedure for other patient related reason
3.8
6.7
26
66
K02.1
ICD-10 Finland
Caries of dentine
0.9
6.7
1932
20608
N81.1
ICD-10 Finland
Cystocele
0.6
6.7
118
1805
GCA12
NOMESCO Finland
Bronchoscopic removal of foreign body
38.7
6.6
8
*
R86
ICPC
Benign neoplasm respiratory
38.7
6.6
8
*
GAW96
NOMESCO Finland
Other operation on chest wall, pleura and diaphragm
38.7
6.6
8
*
C09AA05
ATC
ramipril; oral
1.2
6.6
1296
10908
J01.1
ICD-10 Finland
Acute frontal sinusitis
4.1
6.6
24
57
LEF00
NOMESCO Finland
Anterior colporraphy with sutures for primary cystocele
0.5
6.6
54
1009
PEN24
NOMESCO Finland
Plastic repair of deep femoral artery
4.4
6.6
22
48
D38.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thymus
10.6
6.6
12
11
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
2.5
6.6
50
196
XCK10
NOMESCO Finland
Photography of fundus of eye
1.3
6.6
469
3519
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
3.1
6.6
33
102
B01AC06
ATC
acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)
1.7
6.6
132
765
GE1BE
NOMESCO Finland
Mediastinal ultrasound examinaiton through oesophagus
6.5
6.6
16
24
5823
FHL
Lung avobiopsy and wedge resection
16.1
6.6
10
6
I21.90
ICD-10 Finland
Myocardial infarction (acute) UNS no detected stenosis of the coronary artery
2.0
6.6
74
352
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
2.5
6.6
47
181
8070/3-C32.1
ICD-O-3
Squamous cell carcinoma, NOS, of supraglottis
21.8
6.6
9
*
AA049
NOMESCO Finland
Radiotherapy of metasthasis in the brain
21.8
6.6
9
*
N05AF05
ATC
zuclopenthixol; systemic
3.0
6.5
35
114
R04.0
ICD-10 Finland
Epistaxis
1.4
6.5
306
2153
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
0.6
6.5
127
1903
UJC02
NOMESCO Finland
Rigid oesophagoscopy
3.0
6.5
34
109
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.5
6.5
224
1487
RK250
NOMESCO Finland
NA
4.5
6.5
21
45
NB6AA
NOMESCO Finland
Humerus X-ray examination
2.0
6.4
75
363
K02.0
ICD-10 Finland
Caries limited to enamel
0.7
6.4
208
2833
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
2.0
6.4
77
377
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.2
6.4
1135
9469
R79
ICPC
Chronic bronchitis
8.4
6.4
13
15
TDA90
SPAT
NA
0.4
6.4
31
686
WX111
NOMESCO Finland
Local infiltration anesthesia
0.5
6.4
52
969
SPAT1324
SPAT
Screening procedure
0.7
6.4
192
2644
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.5
6.3
225
1499
GCA08
NOMESCO Finland
Bronchoscopic excsion of lesion of bronchus
67.6
6.3
7
*
R03AL07
ATC
formoterol and glycopyrronium bromide; inhalant
67.6
6.3
7
*
D38
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs
67.6
6.3
7
*
B44.1
ICD-10 Finland
Other pulmonary aspergillosis
67.6
6.3
7
*
GDC23
NOMESCO Finland
Lobectomy and segment resection of lung
67.6
6.3
7
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.4
6.3
262
1803
PH2CD
NOMESCO Finland
Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity
3.0
6.3
33
106
L72.1
ICD-10 Finland
Trichilemmal cyst
1.4
6.3
245
1666
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
3.7
6.3
25
65
A02BX05
ATC
bismuth subcitrate; oral
2.0
6.3
70
334
D72.1
ICD-10 Finland
Eosinophilia
13.8
6.3
10
7
GEB30
NOMESCO Finland
Mediastinotomy and excision of lesion
13.8
6.3
10
7
2123A
ICD-9 Finland
Benign neoplasm of respiratory and intrathoracic organs, Bronchus and lung
13.8
6.3
10
7
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
1.7
6.3
120
689
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
5.5
6.2
17
30
OAB44
SPAT
NA
0.5
6.2
38
775
NF3AA
NOMESCO Finland
Femur X-ray examination
2.0
6.2
74
363
E34.0
ICD-10 Finland
Carcinoid syndrome
3.8
6.2
24
61
A01AB10
ATC
natamycin; local oral
1.9
6.2
84
431
G03AC03
ATC
levonorgestrel; systemic
0.7
6.2
146
2104
Z72.1
ICD-10 Finland
Alcohol use
2.6
6.2
42
159
J69.8
ICD-10 Finland
Pneumonitis due to other solids and liquids
+∞
6.2
6
*
GAE16
NOMESCO Finland
Resection of chest wall
+∞
6.2
6
*
3026
Kela drug reimbursment
Lorlatinib
+∞
6.2
6
*
J15.1
ICD-10 Finland
Pneumonia due to Pseudomonas
+∞
6.2
6
*
8230/3-C34.3
ICD-O-3
Solid carcinoma, NOS, of lower lobe, lung
+∞
6.2
6
*
1XA01
NOMESCO Finland
NA
+∞
6.2
6
*
8140/2-C34.3
ICD-O-3
Adenocarcinoma in situ, NOS, of lower lobe, lung
+∞
6.2
6
*
1350A
ICD-9 Finland
Sarcoidosis[SARCOIDOSIS]
+∞
6.2
6
*
8046/3-C34.0
ICD-O-3
Non-small cell carcinoma of main bronchus
+∞
6.2
6
*
8022/3-C34.1
ICD-O-3
Pleomorphic carcinoma of upper lobe, lung
+∞
6.2
6
*
8260/3-C34.3
ICD-O-3
Papillary adenocarcinoma, NOS, of lower lobe, lung
+∞
6.2
6
*
B44.9
ICD-10 Finland
Aspergillosis, unspecified
+∞
6.2
6
*
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
+∞
6.2
6
*
GCA40
NOMESCO Finland
Closure of bronchopleural fistula
+∞
6.2
6
*
8551/3-C34.9
ICD-O-3
Acinar cell cystadenocarcinoma of lung, NOS
+∞
6.2
6
*
1623X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,EI HIST/SYTOL DG]
+∞
6.2
6
*
C39.0
ICD-10 Finland
Malignant neoplasm: Upper respiratory tract, part unspecified
+∞
6.2
6
*
49109
ICD-8 Finland
Chronic bronchitis, Unspecified
+∞
6.2
6
*
J95.8
ICD-10 Finland
Other postprocedural respiratory disorders
+∞
6.2
6
*
01101
ICD-8 Finland
Pulmonary tuberculosis, Cavernosa
+∞
6.2
6
*
J62.8
ICD-10 Finland
Pneumoconiosis due to other dust containing silica
+∞
6.2
6
*
J86
ICD-10 Finland
Pyothorax
+∞
6.2
6
*
8022/3-C34.3
ICD-O-3
Pleomorphic carcinoma of lower lobe, lung
+∞
6.2
6
*
J38.7
ICD-10 Finland
Other diseases of larynx
7.9
6.2
13
16
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.2
6.2
666
5280
FE2AT
NOMESCO Finland
Pericardial cathetrisation with ultrasound guidance
10.7
6.2
11
10
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
6.3
6.2
15
23
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
2.6
6.1
41
153
I49.3
ICD-10 Finland
Ventricular premature depolarization
0.7
6.1
149
2133
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
5.7
6.1
16
27
PDQ22
NOMESCO Finland
Insertion of endovascular graft into a. iliaca externa
5.0
6.1
18
35
ZPB40
NOMESCO Finland
Polytetrafluoroethylene
5.0
6.1
18
35
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
5.3
6.1
17
31
PD4HE
NOMESCO Finland
Postoperative lower extremity artery ultrasound examination with Doppler method
5.3
6.1
17
31
R03
ICPC
Wheezing
2.8
6.1
36
125
E000002
ATC
NA
1.3
6.1
360
2631
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
2.0
6.1
73
360
B18.2
ICD-10 Finland
Chronic viral hepatitis C
4.0
6.1
22
53
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
2.4
6.1
45
179
R07.1
ICD-10 Finland
Chest pain on breathing
2.3
6.1
51
216
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
2.4
6.1
47
190
GD1AA
SPAT
NA
1.6
6.0
157
976
D06BB10
ATC
imiquimod; topical
0.6
6.0
80
1307
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
3.3
6.0
28
83
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.4
6.0
296
2101
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.2
6.0
940
7746
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.5
6.0
183
1182
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
2.6
6.0
40
149
A41.8
ICD-10 Finland
Other specified sepsis
2.1
6.0
61
281
SGA01
NOMESCO Finland
Tooth opening as first aid
0.7
6.0
288
3686
N05AA01
ATC
chlorpromazine; systemic, rectal
2.5
6.0
43
166
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3006315) Basophils [#/volume] in Blood
4762
25074
2.35
323.31
7.0
4.6
e9/l
0.0
0.0
5.19
4142
20888
(3023383) Lactate [Moles/volume] in Pleural fluid
212
37
50.17
322.53
1.3
1.4
mmol/l
3.8
3.6
0.08
204
31
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1536
4666
3.20
318.15
2.0
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
4836
25792
2.33
316.05
7.2
4.8
e9/l
0.2
0.2
0.52
4240
21819
(3003396) Base excess in Arterial blood by calculation
1759
5831
2.97
313.11
7.2
6.0
mmol/l
1.6
0.5
30.13
1492
4490
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1757
5831
2.97
312.02
7.2
6.0
kpa
5.4
5.0
38.40
1663
5594
(3018010) Neutrophils/100 leukocytes in Blood
4534
23644
2.31
310.56
7.0
4.8
%
62.4
57.3
129.28
4414
21522
(3027801) Oxygen [Partial pressure] in Arterial blood
1753
5828
2.96
310.18
7.2
6.0
kpa
11.2
13.3
57.10
1660
5590
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1526
4701
3.15
308.06
2.0
1.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
2715
8312
3.58
307.65
4.3
2.7
mmol/l
0.8
0.8
45.51
2621
7675
(3010813) Leukocytes [#/volume] in Blood
6021
64487
0.37
307.65
42.5
19.1
e9/l
8.1
6.6
137.22
5816
61872
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
1434
405
35.93
307.65
1.4
1.3
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
1392
506
27.72
307.65
2.1
2.0
ug/l
31.0
20.8
3.77
1374
494
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
4651
58200
0.33
307.65
3.9
4.7
mmol/l
1.4
1.4
20.17
4000
52263
(3036782) Glucose [Moles/volume] in Pleural fluid
540
198
24.77
307.65
1.4
1.2
mmol/l
5.7
6.9
6.96
515
176
(3022096) Basophils/100 leukocytes in Blood
4554
22506
2.50
307.65
7.1
4.9
%
0.6
0.7
16.18
4438
20450
(3026361) Erythrocytes [#/volume] in Blood
6020
64489
0.37
307.65
42.4
19.1
e12/l
4.2
4.5
197.23
5817
61868
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2352
6794
3.67
307.65
3.3
4.3
ug/l
54.4
24.2
2.50
2135
5606
(40768806) Pleura Pathology biopsy report
719
204
32.71
307.65
1.7
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
719
258
25.85
307.65
1.9
1.9
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
677
228
27.41
307.65
1.5
1.2
e6/l
60669.8
23492.3
1.92
443
111
(3003434) Protein [Mass/volume] in Pleural fluid
801
291
25.78
307.65
1.5
1.3
g/l
38.7
27.2
39.03
755
247
(3007461) Platelets [#/volume] in Blood
6021
64465
0.37
307.65
42.5
19.1
e9/l
269.6
236.4
173.84
5844
62131
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
5074
58929
0.38
307.65
4.9
5.0
mmol/l
6.2
6.1
5.90
4436
52425
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
588
174
30.88
307.65
1.3
1.2
u/l
684.6
328.4
1.78
575
166
(3019069) Monocytes/100 leukocytes in Blood
4626
23430
2.44
307.65
7.4
5.1
%
9.1
8.9
2.02
4504
21354
(3000963) Hemoglobin [Mass/volume] in Blood
6021
64497
0.37
307.65
42.7
19.2
g/l
126.0
135.5
307.65
5919
63183
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
519
101
46.61
307.65
1.3
1.2
u/l
13.3
11.3
0.37
506
92
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4733
58746
0.33
307.65
3.9
4.8
mmol/l
4.4
4.5
3.65
4120
53128
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
2025
6469
3.17
307.65
4.2
3.8
u/l
253.3
249.4
0.35
1972
6052
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
767
1160
6.09
307.65
1.3
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4549
56086
0.37
307.65
3.5
4.2
mmol/l
1.3
1.3
8.39
3873
49845
(3035637) Corticotropin [Mass/volume] in Plasma
526
464
10.24
307.65
1.6
1.5
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
4598
23286
2.43
307.65
7.2
4.9
%
2.4
2.9
40.94
4480
21134
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
358
125
25.48
307.65
3.1
3.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1389
3610
3.72
307.65
5.3
2.1
nmol/l
426.8
387.7
7.33
1337
3289
(42870588) Differential panel, method unspecified - Blood
3843
16827
2.68
307.65
6.7
4.8
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
541
220
22.33
307.65
1.5
1.3
—
—
—
0
0
(3024731) MCV [Entitic volume]
6021
64487
0.37
307.65
42.3
19.1
fl
91.6
91.7
0.49
5913
63147
(3035941) MCH [Entitic mass]
6020
64478
0.37
307.65
42.3
19.0
pg
30.1
30.5
48.15
5911
63143
(3023368) Bacteria identified in Blood by Culture
3641
13639
3.18
307.65
4.9
3.5
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
225
30
65.78
307.65
1.3
1.1
ug/l
475.6
1012.2
0.24
160
14
(3012441) Differential panel - Pleural fluid
656
207
29.18
307.65
1.5
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
1443
151
97.41
307.65
1.2
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
377
140
24.00
307.65
1.8
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
4648
23985
2.38
307.65
7.3
5.0
%
21.9
27.7
202.66
4517
21679
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4625
56578
0.37
307.65
5.8
6.4
mmol/mol
41.4
40.4
8.07
4055
51205
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
2164
7027
3.16
307.65
2.0
1.5
—
—
—
0
0
(3035880) pH of Pleural fluid
344
84
36.39
307.65
1.3
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4937
60265
0.32
307.65
4.3
5.4
mmol/l
2.6
2.6
1.30
4234
54326
(4010399)
1231
2536
4.66
307.65
1.4
1.3
—
—
—
0
0
(4035726)
2786
4866
6.68
307.65
1.5
1.3
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
720
262
25.49
307.65
1.5
1.2
e6/l
2583.9
1144.2
5.20
546
160
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
1527
737
21.20
307.65
2.3
2.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
4746
24874
2.36
307.65
7.0
4.6
e9/l
0.7
0.6
97.00
4118
20693
(3019198) Lymphocytes [#/volume] in Blood
4786
25633
2.30
306.19
7.1
4.7
e9/l
1.7
1.9
4.75
4204
21770
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
1047
2598
3.77
295.23
8.1
8.2
mmol/l
25.0
23.8
32.12
1008
2439
(3013650) Neutrophils [#/volume] in Blood by Automated count
5327
30231
2.27
290.50
15.1
7.3
e9/l
5.0
4.1
89.89
4747
25694
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
5913
62696
0.42
289.24
18.8
9.6
u/l
25.3
25.4
0.02
5804
59577
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
435
534
7.27
269.87
1.5
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
226
96
20.63
267.26
1.6
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
354
348
9.02
262.50
1.5
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
5134
29414
2.17
262.09
10.7
5.4
umol/l
10.1
12.7
27.81
5022
27769
(3042936) Bacteria identified in Isolate by Culture
1836
6808
2.65
260.03
2.0
1.9
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
424
529
7.15
259.26
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
388
437
7.89
258.74
1.3
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
388
437
7.89
258.74
1.3
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
5996
62697
0.44
257.62
32.8
15.4
mmol/l
4.0
4.0
5.00
5858
60747
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
200
69
25.33
255.23
1.3
1.4
%
66.6
67.0
0.03
175
54
(3018677) aPTT in Platelet poor plasma by Coagulation assay
2204
9043
2.44
251.62
2.1
1.8
s
29.9
29.9
0.17
2164
8777
(3019550) Sodium [Moles/volume] in Serum or Plasma
5998
62551
0.44
248.65
32.7
15.2
mmol/l
138.3
139.8
233.22
5874
60708
(3001893) Eosinophils/100 leukocytes in Pleural fluid
181
52
30.36
244.56
1.3
1.5
%
4.0
2.1
1.16
166
41
(3018418) pH of Serum or Plasma
3463
17379
2.16
243.31
5.3
3.5
ph
7.4
7.4
1.00
608
3184
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
1042
2997
3.24
232.08
6.9
6.0
mmol/l
25.8
24.2
34.88
1034
2973
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
293
263
9.82
231.81
1.6
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
343
380
7.99
231.64
1.5
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
281
246
10.05
226.17
1.5
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
308
311
8.74
223.64
1.5
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
4537
25752
2.04
223.56
7.7
9.2
inr
1.2
1.4
5.00
952
7075
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
152
32
41.31
222.22
1.4
1.3
%
17.2
28.1
1.06
137
23
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
737
1746
3.85
219.85
2.0
1.7
ug/l
1.8
2.7
0.89
667
1514
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
4688
27042
2.02
219.28
8.0
4.8
mmol/l
1.2
1.2
0.47
4482
23877
(3016502) Oxygen saturation in Arterial blood
1488
5388
2.64
217.63
7.9
6.3
%
94.8
96.4
16.08
1440
5191
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
342
413
7.32
214.83
1.3
1.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
1344
4687
2.71
211.26
7.0
5.7
mmol/l
1.2
1.4
5.24
1290
4561
(3000919) Neutrophils/100 leukocytes in Pleural fluid
159
49
28.24
210.28
1.3
1.5
%
15.7
18.9
0.38
152
43
(40761511) CBC panel - Blood by Automated count
5742
59991
0.48
206.61
25.8
12.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
5003
30093
1.97
200.39
9.0
5.4
mmol/l
1.2
1.2
0.01
4331
24984
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4840
52967
0.52
187.28
5.5
4.4
mu/l
1.9
2.1
3.05
4306
47018
(3019060) Gas panel - Arterial blood
984
3089
2.94
186.96
4.3
4.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
271
297
8.02
184.41
1.6
1.2
—
—
—
0
0
(3000492) Spirometry study
913
2788
3.01
181.96
1.7
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
5271
56029
0.52
181.80
29.2
12.7
ml/min/173m2
77.1
73.8
27.28
4710
45532
(3033658) Prothrombin time (PT) actual/Normal
2818
14371
1.99
176.72
5.6
3.4
%
90.5
85.7
21.94
2775
14049
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1342
5140
2.45
171.57
8.3
6.5
g/l
120.8
120.3
0.35
1304
4944
(3009343) pH of Capillary blood
878
2721
2.95
170.05
4.3
2.8
ph
7.4
7.4
0.13
103
371
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
852
2605
2.99
168.96
4.2
2.7
mmol/l
2.7
1.3
19.56
707
1782
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
923
2963
2.86
167.65
9.4
7.8
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
881
2762
2.92
167.04
4.3
2.8
kpa
5.3
5.0
15.96
826
2502
(3024561) Albumin [Mass/volume] in Serum or Plasma
4328
25957
1.83
160.85
6.0
4.1
g/l
32.6
35.5
161.45
4106
23868
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
651
1756
3.34
158.81
2.3
2.6
u/ml
0.3
0.4
2.76
356
975
(3000991) Gas panel - Venous blood
1197
4507
2.47
157.91
8.1
6.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
2570
13224
1.93
152.75
11.3
5.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
222
242
8.02
151.62
1.7
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
879
16547
0.39
151.03
1.6
1.6
mmol/l
1.4
1.3
3.23
749
13434
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
2321
11580
1.97
150.71
5.4
2.9
mmol/l
2.5
2.5
91.53
2127
10142
(3022313) Gas panel - Capillary blood
662
1931
3.09
141.68
4.5
2.8
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
369
722
4.52
140.57
1.3
1.4
u/l
14.4
10.3
4.34
303
570
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
518
1303
3.55
140.38
1.4
1.6
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
88
13
58.45
137.38
1.4
1.2
%
19.7
19.8
—
79
8
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2934
16188
1.82
137.25
4.4
2.9
u/l
32.3
36.1
1.33
2825
15235
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
131
75
15.14
135.25
2.7
2.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2404
30814
0.54
133.78
4.4
5.7
ug/l
2.4
4.4
6.86
2042
27446
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
810
2724
2.70
133.61
1.6
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
157
127
10.74
133.00
1.7
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
1170
4700
2.30
132.05
1.9
2.3
g/l
64.7
66.8
15.47
1090
4188
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
133
90
12.81
125.56
1.1
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1807
24904
0.52
125.48
3.9
4.8
%
20.8
22.5
5.77
879
13747
(3015377) Calcium [Moles/volume] in Serum or Plasma
3414
20092
1.74
125.22
5.6
3.1
mmol/l
2.4
2.4
5.55
3150
17011
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
139
106
11.38
122.23
1.8
1.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
948
3599
2.40
121.11
9.2
7.3
%
93.3
94.6
7.09
943
3592
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
139
108
11.16
120.80
1.8
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1104
17607
0.47
117.54
3.1
3.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
390
932
3.70
113.67
3.9
2.9
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
1579
7517
1.97
113.31
7.6
5.6
mmol/l
103.8
104.8
12.54
1548
7381
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
184
234
6.85
110.19
1.3
1.2
u/l
26.1
34.9
2.31
176
185
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
168
198
7.38
107.52
1.7
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
824
3117
2.39
105.51
1.9
1.5
—
—
—
0
0
(44806118)
178
230
6.73
105.08
1.5
1.1
—
—
—
0
0
(44790047)
178
230
6.73
105.08
1.5
1.1
—
—
—
0
0
(44790049)
178
230
6.73
105.08
1.5
1.1
—
—
—
0
0
(44790048)
178
230
6.73
105.08
1.5
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
85
32
22.92
104.93
1.3
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
268
526
4.46
101.54
1.2
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
158
190
7.22
99.39
1.3
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
158
190
7.22
99.39
1.3
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
158
190
7.22
99.39
1.3
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
175
238
6.39
98.53
1.3
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
183
262
6.08
98.08
1.3
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
832
3262
2.30
97.91
1.6
1.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
379
989
3.38
96.69
4.8
2.7
mmol/l
3.0
2.2
5.12
304
595
(3027315) Oxygen [Partial pressure] in Blood
380
994
3.37
96.58
4.8
2.7
kpa
8.1
8.8
13.64
373
971
(3013290) Carbon dioxide [Partial pressure] in Blood
379
990
3.38
96.53
4.8
2.7
kpa
5.1
4.9
7.04
372
967
(3028626) Oxygen [Partial pressure] in Capillary blood
354
889
3.50
95.77
3.0
2.4
kpa
7.6
8.2
8.77
327
820
(40768804) Tissue Pathology biopsy report
3692
23346
1.60
94.64
2.7
2.2
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
74
26
24.53
93.55
1.4
1.6
%
10.1
12.8
—
50
9
(3006184) Hemoglobin [Mass/volume] in Capillary blood
376
1000
3.31
93.07
2.1
2.1
g/l
121.1
129.0
4.67
201
806
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1238
17811
0.53
91.09
2.9
3.3
ug/l
0.8
0.8
0.51
860
13022
(3020682) Albumin/Creatinine [Ratio] in Urine
1701
22320
0.57
90.53
3.8
4.0
mg/mmol
12.7
7.6
3.32
1076
14031
(3010421) pH of Blood
409
1175
3.07
89.15
4.9
2.7
ph
7.4
7.4
0.46
372
967
(3044640) Blood type and Crossmatch panel - Blood
3055
18661
1.61
88.87
2.8
2.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
2465
14273
1.66
88.85
2.7
2.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
4505
46858
0.64
88.70
39.1
17.2
g/l
328.4
332.5
151.39
4439
46485
(3009508) Creatinine [Moles/volume] in Urine
1604
21271
0.57
88.14
2.9
3.1
mmol/l
7.2
7.5
2.11
1264
17541
(3012516) Albumin [Mass/volume] in Urine
1590
21113
0.57
87.67
3.0
3.2
mg/l
508.2
309.2
0.88
1042
13293
(3041918) Cholesterol [Moles/volume] in Pleural fluid
91
60
13.09
87.13
1.2
1.2
mmol/l
2.0
1.3
1.64
84
20
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
2037
11265
1.71
87.02
4.7
3.3
ng/l
293.0
740.7
3.90
1786
9498
(3021901) Oxygen saturation in Capillary blood
307
766
3.51
83.81
2.9
2.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
515
1736
2.63
83.57
5.1
2.8
mmol/l
25.9
24.5
16.24
489
1546
(3015235) Bicarbonate [Moles/volume] in Capillary blood
379
1084
3.08
83.19
3.3
2.5
mmol/l
25.7
23.8
9.45
327
952
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3992
42169
0.65
79.40
4.8
3.6
pmol/l
15.2
15.0
7.06
3600
37151
(3004809) Band form neutrophils/100 leukocytes in Blood
298
766
3.41
77.73
2.5
3.5
%
1.5
1.5
0.10
252
563
(3013826) Glucose [Moles/volume] in Serum or Plasma
5024
35075
1.52
76.08
7.2
3.9
mmol/l
6.8
6.8
1.42
4874
32679
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
513
1824
2.49
74.47
2.0
2.1
ug/l
325.1
813.7
2.35
470
1735
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
522
1891
2.45
72.78
1.9
1.6
—
—
—
0
0
(3014891) Appearance of Pleural fluid
64
31
17.77
71.36
1.8
1.3
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
52
14
31.94
71.19
1.2
1.1
u/l
21.7
11.3
—
42
8
(40767503) Oxygen content in Capillary blood by calculation
327
955
3.00
69.17
2.7
2.2
%
14.8
16.4
6.85
153
503
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
986
4687
1.90
68.43
2.8
2.3
u/l
33.4
42.9
3.61
870
4016
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
282
761
3.24
68.10
3.7
3.4
%
61.5
56.8
5.66
282
761
(4015189)
63
33
16.43
67.80
1.8
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
210
471
3.88
66.83
2.7
3.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
5989
57390
0.67
62.14
31.7
11.6
mg/l
37.9
24.8
136.61
5717
43908
(3009542) Hematocrit [Volume Fraction] of Blood
5066
50027
0.69
60.66
32.0
14.2
%
37.5
39.0
20.93
3249
31207
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2719
17278
1.50
60.52
4.3
2.3
u/l
58.6
61.8
1.91
2564
15730
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
572
2335
2.17
60.20
3.0
3.5
mmol/l
24.5
23.8
5.73
538
2075
(3009445) Proteinase 3 Ab [Units/volume] in Serum
456
1692
2.38
60.15
1.3
1.2
u/ml
17.7
8.0
—
9
16
(3017181) Myelocytes/100 leukocytes in Blood
894
4299
1.87
59.45
3.3
3.6
%
1.2
0.9
2.37
464
1055
(3044889) 12 lead EKG panel
4311
43751
0.69
59.25
4.8
4.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2444
27442
0.67
57.47
1.9
2.0
pmol/l
89.4
93.9
5.39
1311
14226
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1714
9942
1.59
57.34
1.6
1.5
mg/l
2.0
1.5
2.73
1431
7617
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
92
112
7.09
57.30
1.2
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
92
112
7.09
57.30
1.2
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
92
112
7.09
57.30
1.2
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
92
112
7.09
57.30
1.2
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
465
1782
2.30
56.95
1.8
1.5
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
726
3307
1.96
56.76
7.4
5.7
mmol/l
25.6
24.1
24.05
681
3045
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
79
83
8.20
55.55
1.2
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
79
83
8.20
55.55
1.2
1.7
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
984
4990
1.77
54.77
4.9
5.6
mmol/l
9.3
10.4
5.06
928
4689
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
79
85
8.01
54.52
1.2
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
1942
11711
1.54
54.32
2.8
2.6
mosm/kgh2o
539.8
569.3
7.37
1690
9859
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
72
71
8.73
53.14
1.1
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
999
5138
1.75
52.85
3.4
3.2
mmol/l
2.4
1.5
11.13
840
4104
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1274
7003
1.65
52.64
4.6
4.8
mmol/l
1.0
1.0
0.10
1192
6467
(3021447) Carbon dioxide [Partial pressure] in Venous blood
993
5173
1.72
50.04
3.4
3.2
kpa
6.0
5.7
8.78
958
5056
(3021440) Promyelocytes/100 leukocytes in Blood
831
4131
1.79
49.23
3.4
3.6
%
0.2
0.2
0.12
429
980
(3023323) Follitropin [Units/volume] in Serum or Plasma
222
637
3.03
48.42
1.3
1.4
iu/l
31.8
37.1
1.20
175
544
(3002385) Erythrocyte distribution width [Ratio]
4734
46582
0.72
48.00
37.2
15.7
%
14.5
13.7
226.57
4665
45341
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
257
813
2.75
47.02
1.8
1.2
mg/l
11.4
11.6
0.14
240
742
(3051651) Icteric interference index of Serum or Plasma
134
282
4.11
46.53
4.3
3.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
53
41
11.11
46.15
1.2
1.0
u/ml
0.3
0.2
—
34
8
(3000494) Fungus identified in Specimen by Culture
1046
5653
1.66
45.72
1.5
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
786
3935
1.78
45.32
3.3
3.4
%
0.7
0.6
0.35
344
754
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
221
667
2.88
44.12
4.3
3.9
iu/ml
545.7
1017.0
0.58
31
82
(3003181) Sodium [Moles/volume] in Urine
264
889
2.59
42.76
1.3
1.3
mmol/l
64.5
62.9
0.24
202
720
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
37
17
18.68
42.08
1.1
1.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
359
1411
2.23
41.32
1.2
1.1
u/ml
257.4
272.3
0.11
325
1271
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
363
1434
2.21
41.27
1.7
1.2
u/l
36.9
37.9
0.37
309
1175
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
291
1047
2.42
41.03
1.5
1.7
iu/l
3.1
5.0
2.89
54
344
(3011412) CD3 cells [#/volume] in Blood
120
258
4.02
40.55
1.9
2.2
e9/l
0.9
1.1
0.92
83
166
(3021589) Normoblasts [#/volume] in Blood
3522
24716
1.36
40.51
14.0
8.6
e9/l
0.0
0.0
0.45
2742
20250
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
266
926
2.50
40.25
1.4
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
790
4107
1.71
39.68
1.3
1.5
—
—
—
0
0
(3002256) Pathology report gross observation
1374
8168
1.52
39.58
1.4
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2072
22821
0.71
38.80
2.1
2.0
nmol/l
75.7
79.7
7.74
1803
19790
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1956
21752
0.70
38.74
4.0
3.8
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
213
683
2.71
38.02
1.5
1.9
mu/l
320.6
290.4
0.86
208
627
(3017354) Segmented neutrophils/100 leukocytes in Blood
171
486
3.05
37.97
2.3
3.5
%
60.0
56.1
1.06
125
290
(3052851) Hemolysis interference index of Serum or Plasma
383
1605
2.09
37.48
4.0
3.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
2742
18664
1.37
37.46
3.3
3.1
e6/l
65.9
109.1
1.67
2136
14181
(3047181) Lactate [Moles/volume] in Blood
369
1543
2.09
36.32
6.7
4.7
mmol/l
1.2
1.3
2.36
319
1347
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
325
1296
2.19
36.11
1.4
1.5
titre
131.4
285.8
—
7
60
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1016
5787
1.57
35.24
2.6
2.5
umol/l
8.8
10.4
1.06
885
5083
(36304419) Bacteria [Presence] in Urine
2417
16272
1.37
34.81
3.2
3.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
2766
28738
0.74
34.35
3.7
3.6
estimate
0.0
0.0
1.60
578
4986
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2711
18632
1.35
34.05
3.1
2.6
ng/l
1465.6
1425.4
0.22
2466
16079
(3030467) Casts [#/volume] in Urine by Automated count
2526
17182
1.36
33.89
3.3
3.0
e6/l
0.7
0.4
4.91
1934
12856
(3021601) Nitrite [Presence] in Urine by Test strip
2724
28324
0.74
33.83
5.0
4.7
estimate
0.0
0.0
0.00
605
5117
(3035350) Ketones [Presence] in Urine by Test strip
2727
28277
0.75
32.91
3.6
3.5
estimate
0.0
0.0
0.50
600
5054
(3025159) Blasts/100 leukocytes in Blood
728
3903
1.65
32.33
3.5
3.5
%
0.0
0.7
2.50
370
830
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
324
1352
2.09
32.07
1.2
1.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
287
1165
2.14
30.52
1.8
2.1
%
214.7
200.1
2.00
272
1099
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
58
85
5.87
30.51
1.2
1.6
u/ml
1911.0
71815.7
—
10
12
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
656
8703
0.62
30.27
11.5
6.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
96
220
3.76
29.82
2.6
3.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
130
365
3.08
29.56
1.1
1.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
301
1262
2.08
29.44
1.9
2.1
g/l
4.0
3.5
5.69
287
1193
(21494815) CD4 cells/100 lymphocytes in Specimen
99
235
3.63
29.26
1.8
2.0
%
32.4
40.1
—
7
33
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
65
111
5.04
29.15
1.6
2.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
339
5300
0.53
28.87
1.4
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
88
196
3.87
28.46
1.7
2.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
773
4339
1.57
28.30
3.2
2.6
kpa
4.4
4.4
0.14
740
4220
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
298
1266
2.05
28.14
1.8
1.9
%
88.9
87.3
0.56
292
1178
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1541
9929
1.40
28.08
3.0
2.9
e6/l
2.4
1.8
1.78
826
5529
(3019150) Specific gravity of Urine by Refractometry
1081
12728
0.69
27.76
4.0
4.0
kg/l
1.0
1.0
0.06
198
1947
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
869
5030
1.53
27.71
3.0
2.4
ng/l
225.0
209.9
0.45
809
4621
(3007853) Bacteria identified in Skin by Aerobe culture
965
5715
1.50
27.60
1.7
1.7
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
89
207
3.70
27.11
1.7
2.1
%
13.7
17.7
0.92
24
65
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
635
8257
0.63
26.56
3.8
4.9
%
33.0
33.0
0.02
416
5235
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1227
14011
0.71
26.24
1.6
1.7
pmol/l
17325678.9
29527877.3
0.43
987
11237
(3021960) Folate [Moles/volume] in Serum or Plasma
1427
15839
0.73
25.50
1.5
1.5
nmol/l
19.8
20.4
0.59
1253
13230
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
3048
21954
1.29
25.41
3.3
3.1
—
0.4
—
0
7
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
386
5614
0.57
25.41
1.6
1.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
82
190
3.72
25.14
2.1
2.1
e6/l
504.0
565.7
0.31
31
73
(3028433) Virus identified in Specimen by Culture
52
85
5.26
24.50
1.1
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
1438
15836
0.73
24.20
4.0
3.9
estimate
0.0
0.0
0.18
524
4842
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
466
2396
1.70
24.15
2.6
3.4
u/ml
584.1
1247.1
0.92
399
2056
(3036489) Thrombin time
361
1727
1.82
24.01
1.7
1.7
s
22.3
21.8
0.34
338
1541
(3018572) Chloride [Moles/volume] in Blood
264
1166
1.96
22.43
7.5
5.3
mmol/l
103.7
105.6
7.13
235
1048
(3039000) Anion gap in Blood
264
1166
1.96
22.43
7.5
5.3
mmol/l
10.4
11.2
4.35
235
1048
(3008536) Aspergillus sp Ab [Presence] in Serum
29
27
9.21
22.31
1.2
2.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
63
133
4.07
21.97
1.7
2.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1531
10240
1.34
21.39
5.6
3.9
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
524
2864
1.60
21.37
2.2
2.2
g/l
10.0
10.9
4.96
478
2575
(3027945) Reticulocytes/100 erythrocytes in Blood
1125
7185
1.39
21.09
2.3
2.1
%
1.8
1.7
2.36
1004
6290
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
158
585
2.33
21.07
1.2
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
1843
12694
1.30
20.84
2.6
2.5
e6/l
6.0
4.2
7.14
1647
11000
(3018095) Leukocytes [#/volume] in Urine
2924
21334
1.26
20.78
3.8
3.5
e6/l
83.6
117.4
1.52
2197
15191
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
183
726
2.18
20.72
2.9
3.1
u/ml
45.0
33.7
0.63
175
703
(40768795) Lymph node Pathology biopsy report
146
526
2.40
20.70
1.2
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
88
244
3.10
20.56
2.2
2.0
ph
7.4
7.4
0.41
35
79
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
3698
27745
1.24
20.33
4.4
3.8
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
146
533
2.36
20.11
2.2
2.0
u/ml
5753.9
2407.5
0.25
11
31
(3051611) Lipemic interference index of Serum or Plasma
162
621
2.25
19.95
4.1
2.9
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
87
247
3.03
19.56
1.2
1.3
g/l
2.6
3.0
0.85
53
161
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
169
2900
0.49
19.12
1.7
1.8
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
86
247
3.00
18.97
1.2
1.3
g/l
6.6
7.3
0.69
52
161
(3024139) IgG subclass 3 [Mass/volume] in Serum
86
247
3.00
18.97
1.2
1.3
g/l
0.5
0.5
0.57
54
161
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
81
1850
0.37
18.94
1.5
1.5
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
222
984
1.95
18.73
1.9
2.5
umol/l
34.8
34.6
0.03
174
809
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
46
86
4.59
18.70
5.2
4.5
u/l
31.5
43.3
1.08
27
30
(4062490)
85
245
2.99
18.64
1.2
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
97
301
2.77
18.64
1.9
1.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
828
5127
1.42
18.47
2.1
2.1
g/l
0.2
0.2
1.24
768
4768
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
229
1034
1.92
18.31
1.4
1.6
iu/ml
44.9
0.6
0.56
71
203
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
63
153
3.54
18.15
2.1
2.2
e6/l
452.6
507.3
0.40
54
131
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
40
68
5.05
18.12
3.3
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
130
482
2.33
17.36
1.3
1.3
mosm/kgh2o
269.9
279.2
3.95
101
359
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
150
595
2.18
17.07
6.0
5.7
mg/l
11.9
11.8
0.10
140
550
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
853
9714
0.72
17.06
1.2
1.2
u/ml
1.9
2.1
0.14
171
2483
(21494755) Public health laboratory ask at order entry panel
123
2247
0.46
16.66
1.3
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
57
1440
0.33
16.55
2.6
1.5
mg/l
4.7
3.0
0.60
50
1003
(3021879) Hepatitis B virus core Ab [Presence] in Serum
425
2359
1.57
16.25
1.2
1.3
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
64
170
3.24
16.12
2.7
2.8
%
39.9
32.9
0.90
15
51
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
5764
45831
1.22
16.04
14.9
6.3
u/l
89.2
79.7
31.26
5657
42505
(3028026) IgM [Mass/volume] in Serum or Plasma
415
2302
1.57
15.91
1.8
1.7
g/l
1.6
1.5
0.34
377
2032
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1177
7908
1.31
15.51
2.2
2.4
%
19.2
23.0
14.03
1049
6642
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
432
2433
1.54
15.49
6.0
3.8
%
1.9
1.5
5.20
401
2300
(3024980) IgG subclass 4 [Mass/volume] in Serum
120
462
2.24
14.75
1.2
1.4
g/l
0.7
0.8
0.30
82
348
(3001964) Herpes simplex virus Ag [Presence] in Specimen
42
89
4.05
14.68
1.4
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
421
2408
1.52
14.08
6.1
3.8
%
0.9
0.9
0.77
391
2270
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
803
5171
1.36
14.07
5.7
3.3
mmol/l
1.2
1.2
0.15
761
4361
(3043409) Potassium [Moles/volume] in Arterial blood
313
1676
1.62
13.95
4.4
3.6
mmol/l
3.9
3.9
0.09
290
1589
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1532
10784
1.26
13.88
2.9
2.7
e6/l
1.2
1.2
0.01
816
6327
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2478
18403
1.21
13.47
2.3
2.0
u/l
153.9
227.6
7.65
2354
17105
(3041096) Erythrocytes [Presence] in Urine by Automated
1400
14489
0.79
13.41
3.7
3.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
66
200
2.84
13.37
2.4
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
623
3907
1.39
12.84
1.4
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
597
3718
1.40
12.82
1.4
1.4
—
—
—
0
0
(3013512) EKG study
1975
19618
0.82
12.70
4.7
3.9
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
1307
9118
1.26
12.68
2.2
2.3
umol/l
10.1
13.0
35.69
1232
8345
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
68
216
2.70
12.64
1.2
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
68
216
2.70
12.64
1.2
1.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
22
30
6.28
12.46
1.7
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1221
8474
1.27
12.35
2.2
2.3
g/l
2.2
2.3
8.79
1150
7748
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
78
269
2.49
12.33
1.2
1.1
titre
145.6
118.6
0.13
16
42
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
78
269
2.49
12.33
1.2
1.1
titre
314.0
105.7
—
5
7
(3027456) Digoxin [Moles/volume] in Serum or Plasma
230
1176
1.69
12.31
3.0
3.0
nmol/l
0.8
0.8
0.68
182
888
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
115
470
2.11
12.27
2.8
2.4
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
15
13
9.88
12.04
1.1
1.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
4368
40313
0.86
11.49
4.4
4.0
—
—
—
0
0
(3020891) Body temperature
383
2245
1.48
11.43
5.0
3.9
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
18
9
17.13
11.38
1.2
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
81
298
2.34
11.17
1.2
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
82
305
2.31
11.04
1.2
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
153
2276
0.57
10.92
1.2
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
47
1057
0.38
10.79
1.4
1.7
—
—
—
0
0
(3004451) EKG impression Narrative
74
267
2.38
10.68
1.5
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
38
95
3.43
10.63
1.2
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
64
1253
0.43
10.56
1.6
1.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
94
379
2.13
10.45
1.2
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1362
13773
0.82
10.12
3.2
3.6
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
43
121
3.05
10.00
2.0
2.2
u/l
16.0
40.7
1.19
36
109
(3026493) Urate [Moles/volume] in Serum or Plasma
1559
15541
0.83
9.97
2.8
2.6
umol/l
3215.5
7150.5
4.14
1303
13125
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
32
75
3.66
9.84
2.4
2.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
358
2136
1.45
9.80
2.7
4.0
u/ml
76.9
59.9
0.67
345
2056
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
276
1563
1.53
9.77
2.2
2.0
g/l
0.0
0.0
0.00
249
1430
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
280
1593
1.52
9.71
2.2
1.9
g/l
0.0
0.0
0.35
249
1434
(3045414) Leukocytes [Presence] in Urine
196
2656
0.62
9.68
1.9
1.9
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
195
1027
1.64
9.42
1.4
1.4
g/l
0.2
0.2
0.43
183
964
(3037522) Nuclear Ab [Titer] in Serum
773
5256
1.28
9.15
1.3
1.3
titre
529.6
528.0
0.01
195
1058
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
143
2059
0.59
9.08
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
57
1095
0.44
9.02
1.6
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2978
23061
1.16
9.00
4.6
3.2
ng/l
45.7
70.1
1.82
2460
17463
(4034850)
138
1988
0.59
8.79
14.6
11.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
128
615
1.79
8.66
7.0
5.3
mmol/l
7.7
7.4
0.36
106
508
(3024928) Oxygen saturation in Venous blood
202
1101
1.58
8.53
2.4
2.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
87
371
2.02
8.44
1.1
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
231
1309
1.52
8.22
3.0
2.8
mg/l
1.5
1.6
1.68
216
1171
(3017446) Testosterone [Moles/volume] in Serum or Plasma
418
4757
0.74
8.13
1.9
2.0
nmol/l
9.6
11.9
6.85
347
4152
(3016038) Potassium [Moles/volume] in Urine
79
330
2.06
8.12
1.2
1.1
mmol/l
36.1
37.7
0.24
68
283
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
196
1077
1.57
8.02
1.5
1.3
g/l
1.1
1.2
1.65
184
1016
(3013139) Helicobacter pylori Ag [Presence] in Stool
292
3513
0.70
8.02
1.2
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
218
1228
1.53
7.99
1.5
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
609
6539
0.78
7.69
1.3
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
20
40
4.28
7.61
1.2
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
485
5348
0.76
7.55
3.6
3.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
43
143
2.58
7.47
2.0
1.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
43
143
2.58
7.47
2.0
1.8
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
284
1713
1.43
7.43
2.2
1.9
g/l
0.1
0.0
0.48
253
1545
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
431
2789
1.34
7.37
1.5
1.5
g/l
1.9
1.5
12.59
363
2339
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
49
175
2.40
7.35
1.2
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
797
5584
1.24
7.32
2.3
2.3
e9/l
71.4
66.7
2.46
536
4285
(3045424) Erythrocytes [Presence] in Urine
52
952
0.46
7.31
1.4
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
402
2587
1.34
7.14
3.8
3.2
pmol/l
4.3
4.4
2.65
364
2248
(3048689) Calprotectin [Mass/mass] in Stool
453
5000
0.76
7.11
1.9
2.1
ug/g
196.5
154.7
1.03
365
3836
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
15
25
5.14
7.00
1.3
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
15
25
5.14
7.00
1.3
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
15
25
5.14
7.00
1.3
1.2
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
67
279
2.06
7.00
1.2
1.2
u/l
34.1
19.8
1.08
60
233
(3044242) Glucose [Moles/volume] in Arterial blood
59
234
2.16
6.98
2.1
1.7
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
20
45
3.81
6.57
1.0
1.0
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
67
287
2.00
6.52
1.2
1.2
u/l
109.3
84.9
0.77
62
242
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
295
1837
1.39
6.48
2.2
1.9
g/l
36.3
38.0
5.12
258
1528
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
15
27
4.76
6.45
2.3
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
149
813
1.58
6.38
1.2
1.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
39
135
2.48
6.30
1.4
1.5
umol/l
71.1
165.5
1.86
27
70
(3036603) Volume of Urine
79
363
1.87
6.28
1.3
1.6
ml
2040.7
1897.9
0.37
36
100
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
285
3299
0.73
6.25
2.3
2.4
au/ml
21.7
29.6
0.56
13
133
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
15
28
4.59
6.20
1.1
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2295
21511
0.88
6.06
2.6
2.6
ug/l
245.8
149.6
19.09
2090
19340
(3022217) INR in Platelet poor plasma by Coagulation assay
1182
8758
1.18
6.04
23.4
27.6
inr
1.4
1.4
0.19
160
1251
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
252
2956
0.72
6.02
1.2
1.3
au/ml
49.7
64.4
0.34
12
150
(3025468) Yersinia sp identified in Specimen by Organism specific culture
114
591
1.66
6.02
1.2
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
114
593
1.65
5.95
1.2
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
114
594
1.65
5.91
1.2
1.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
105
536
1.68
5.89
1.2
1.2
u/l
66.3
66.5
0.01
84
337
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
47
183
2.20
5.87
3.3
2.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
342
2220
1.33
5.80
2.1
1.9
g/l
10.4
10.2
0.42
285
1833
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
49
196
2.14
5.74
1.1
1.2
—
—
—
0
0
(4094501)
118
1574
0.64
5.60
1.1
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
41
154
2.28
5.59
1.1
1.1
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
22
508
0.37
5.58
1.0
1.0
ng/l
612.6
671.1
0.34
17
329
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
67
307
1.87
5.43
1.7
1.5
u/l
5.1
6.6
0.32
39
129
(3027273) Bicarbonate [Moles/volume] in Venous blood
437
2960
1.28
5.42
3.8
2.9
mmol/l
26.0
24.8
10.01
431
2889
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
97
501
1.66
5.25
1.1
1.1
g/l
1.6
1.5
1.02
86
442
(3015171) Extractable nuclear Ab [Units/volume] in Serum
225
1398
1.39
5.10
1.2
1.2
u/ml
1.1
0.8
0.17
19
123
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
762
5516
1.20
5.09
2.3
2.2
ug/l
6.0
8.0
1.92
669
4817
(3024522) Salmonella sp identified in Specimen by Organism specific culture
112
606
1.59
5.06
1.2
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
111
600
1.59
5.04
1.2
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
42
720
0.50
5.03
1.4
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
113
618
1.57
4.89
1.2
1.3
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
22
65
2.90
4.85
1.3
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
133
758
1.51
4.79
1.2
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
313
3420
0.77
4.63
1.2
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
303
2001
1.31
4.62
2.2
2.0
g/l
1.1
1.0
0.28
257
1674
(3010375) cycloSPORINE [Mass/volume] in Blood
36
140
2.20
4.59
34.5
22.6
ug/l
116.0
102.2
0.91
31
122
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
97
521
1.60
4.56
1.2
1.2
u/ml
4.8
3.2
0.38
30
175
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
74
1043
0.60
4.53
1.1
1.1
u/ml
38.9
13.1
—
6
74
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
9
9
8.56
4.52
1.0
1.1
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
16
41
3.34
4.43
1.1
1.3
ng/l
70.8
84.6
0.11
11
30
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
17
46
3.16
4.34
2.4
2.6
mg/l
0.8
1.6
1.04
12
34
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
326
2199
1.28
4.26
2.1
1.9
g/l
3.4
3.0
13.43
268
1687
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
11
22
4.28
4.21
1.1
1.2
u/field
1.0
1.1
—
6
15
(3000060) B lymphocytes [#/volume] in Blood
17
47
3.10
4.20
2.1
2.3
e6/l
9434.0
2464.2
—
10
19
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
46
204
1.93
4.19
1.0
1.0
—
—
—
0
0
(3019225) pH of Specimen
855
6357
1.17
4.19
5.6
3.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3650
32896
0.91
4.18
4.6
2.8
u/l
70.9
52.4
12.00
3379
29653
(3032057) Clostridioides difficile [Presence] in Stool
24
81
2.54
4.18
2.0
1.5
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
18
52
2.96
4.15
1.6
1.7
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
17
48
3.03
4.07
1.2
1.1
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
517
3690
1.21
4.06
3.6
2.8
g/l
122.5
129.0
8.80
509
3604
(3014271) Vancomycin [Susceptibility]
63
313
1.73
4.03
2.9
2.6
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
54
257
1.80
3.99
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
54
257
1.80
3.99
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
91
499
1.57
3.97
1.2
1.2
u/ml
4.1
3.5
0.33
40
211
(40760888) Immunoglobulin light chains.free panel - Serum
217
1400
1.33
3.96
2.5
2.7
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
54
258
1.79
3.94
1.1
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
715
7056
0.85
3.87
1.2
1.2
u/ml
28.2
12.5
1.14
197
2574
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
54
260
1.78
3.85
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
54
260
1.78
3.85
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
54
260
1.78
3.85
1.1
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
345
2376
1.25
3.83
2.1
1.9
g/l
8.1
7.3
10.45
269
1721
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
344
2370
1.25
3.81
2.1
1.9
g/l
4.1
3.8
1.70
265
1647
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
11
24
3.92
3.79
1.0
1.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
344
2373
1.25
3.77
2.1
1.9
—
—
—
0
0
(4024509)
39
619
0.54
3.77
1.5
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
120
708
1.46
3.74
1.2
1.4
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
16
46
2.98
3.73
1.1
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
69
360
1.64
3.71
2.4
2.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
164
1025
1.38
3.70
1.3
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
775
7550
0.87
3.54
1.2
1.2
iu/ml
56.8
34.8
2.19
230
2246
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
399
2818
1.22
3.53
4.6
3.4
%
48.1
45.2
1.56
399
2784
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
97
1214
0.68
3.52
2.2
1.5
nmol/l
1.1
0.7
1.71
78
1030
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
122
732
1.43
3.50
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
394
4054
0.82
3.47
2.7
2.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
846
6378
1.15
3.47
4.9
3.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
107
628
1.46
3.46
1.2
1.4
u/ml
142.4
110.8
0.52
22
150
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
574
4203
1.18
3.44
2.9
3.5
ng/l
83.7
92.3
1.71
493
3525
(3008898) HLA-B27 [Presence]
76
992
0.65
3.42
1.0
1.1
—
—
—
0
0
(1002224) Polysomnography panel
110
1337
0.70
3.42
1.0
1.0
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
37
575
0.55
3.37
1.6
2.0
ug/l
2.0
2.3
0.34
30
481
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
45
215
1.79
3.34
1.0
1.1
mg/l
366.1
324.2
0.45
39
191
(4027681)
34
149
1.95
3.28
1.2
1.2
—
—
—
0
0
(4146454)
61
826
0.63
3.27
2.3
2.7
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
26
103
2.16
3.25
1.2
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
346
3577
0.82
3.22
3.8
3.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
336
3480
0.82
3.19
2.7
2.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
14
41
2.92
3.19
1.1
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
18
61
2.53
3.16
1.1
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
47
233
1.73
3.11
1.0
1.1
mg/l
59.6
45.4
0.98
39
202
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
13
37
3.01
3.10
1.1
1.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
151
962
1.35
3.09
1.3
1.2
u/ml
3.5
5.6
0.25
17
96
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
152
971
1.34
3.06
1.3
1.2
u/ml
9.0
5.6
0.59
30
156
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
123
1434
0.73
3.02
1.4
1.4
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
13
38
2.93
2.98
2.5
3.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
160
1791
0.76
2.98
1.1
1.1
u/ml
4.4
9.1
—
5
32
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
67
369
1.56
2.97
1.2
1.1
%
93.4
96.6
0.52
62
343
(44816559) Phosphatidylethanol [Mass/volume] in Blood
50
691
0.62
2.96
1.1
1.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
136
859
1.36
2.96
3.0
2.0
mmol/l
104.1
106.1
4.33
136
852
(3041354) Potassium [Moles/volume] in Venous blood
136
859
1.36
2.96
3.0
2.0
mmol/l
4.1
4.1
0.55
136
852
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
129
808
1.37
2.95
1.2
1.2
u/ml
8.2
6.3
0.09
11
56
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
6
7
7.33
2.93
1.0
1.0
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
159
1034
1.32
2.86
1.3
1.2
u/ml
28.6
53.9
0.79
15
54
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
358
2563
1.20
2.83
1.2
1.2
iu/ml
131.8
131.5
0.00
66
925
(3004588) Protein electrophoresis panel - Serum or Plasma
569
4236
1.16
2.82
2.1
2.0
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
7
11
5.44
2.81
3.0
1.6
mg/l
2.2
2.7
—
7
6
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
7
11
5.44
2.81
4.0
4.3
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
25
104
2.06
2.81
10.9
16.1
nmol/l
1730.7
1321.2
0.72
25
99
(3045142) Bone marrow Pathology biopsy report
105
642
1.40
2.79
1.2
1.2
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
42
596
0.60
2.79
2.5
3.2
mg/l
23.5
24.2
0.03
34
444
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
23
93
2.12
2.78
1.1
1.1
pmol/l
7.3
6.1
—
5
10
(3004616) Nuclear Ab [Presence] in Serum
85
501
1.46
2.76
1.3
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
105
646
1.39
2.71
1.1
1.3
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
41
205
1.71
2.68
1.0
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
133
853
1.34
2.66
3.0
2.0
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
82
485
1.45
2.63
1.1
1.1
%
120.5
115.4
0.68
75
419
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
110
1272
0.74
2.61
1.4
1.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
23
96
2.05
2.58
1.3
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
167
0.36
2.55
1.3
1.7
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
34
164
1.78
2.52
2.0
1.9
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
10
28
3.06
2.46
1.0
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
65
812
0.68
2.45
1.1
1.1
iu/ml
8.1
585.2
0.93
14
137
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
44
596
0.63
2.45
1.1
1.2
mmol/l
8.3
7.8
0.39
31
406
(3047007) Chlamydophila sp Ab [Presence] in Serum
63
360
1.50
2.43
1.2
1.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
274
1945
1.21
2.42
2.6
2.6
mg/l
41.9
43.8
0.10
211
1604
(3003327) Ova and parasites identified in Stool by Light microscopy
111
1265
0.75
2.42
1.5
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1684
15386
0.92
2.39
1.3
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
29
433
0.57
2.39
1.7
1.5
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
6
10
5.13
2.38
1.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
6
10
5.13
2.38
1.0
1.0
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
67
390
1.47
2.37
1.1
1.1
iu/ml
2.5
2.2
—
5
10
(40768446) Kidney Pathology biopsy report
29
136
1.83
2.37
1.2
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
193
1324
1.25
2.36
1.1
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
166
1787
0.79
2.35
2.3
2.2
ug/min
129.9
102.8
0.40
92
1029
(3014765) Yersinia sp identified in Stool by Organism specific culture
194
1333
1.25
2.34
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
52
288
1.55
2.32
1.1
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
264
1876
1.21
2.32
2.6
2.6
ratio
3.9
2.7
0.24
14
150
(3028707) Methadone [Presence] in Urine by Screen method
31
150
1.77
2.30
1.7
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
167
1130
1.27
2.30
1.8
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
143
1561
0.78
2.28
1.4
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
194
1338
1.25
2.27
1.1
1.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
273
1952
1.20
2.26
2.6
2.6
mg/l
48.9
54.1
0.59
207
1606
(3030313) Adrenal Ab [Titer] in Serum
6
11
4.67
2.23
1.0
1.0
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
43
230
1.60
2.23
2.3
2.2
mmol/l
7.8
9.7
2.49
33
168
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
13
245
0.45
2.23
1.0
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
8
20
3.42
2.18
1.3
1.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
206
1438
1.23
2.18
2.4
3.2
u/ml
145.8
1083.8
2.79
182
1314
(3011335) Digoxin [Mass/volume] in Serum or Plasma
14
51
2.35
2.18
2.6
2.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
23
103
1.91
2.17
8.5
10.9
nmol/l
919.4
819.3
0.34
23
92
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
56
700
0.68
2.16
1.4
1.5
%
68.1
58.8
1.23
36
418
(3002523) Influenza virus A Ag [Presence] in Specimen
51
287
1.52
2.15
1.1
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
42
555
0.65
2.14
1.6
2.1
u/field
3.2
2.4
0.28
17
193
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
13
240
0.46
2.12
1.0
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
327
2391
1.18
2.12
1.3
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
14
52
2.30
2.09
1.3
1.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1864
15033
1.08
2.09
2.2
2.1
mg/l
3.3
3.0
6.03
1600
12621
(3026250) Tacrolimus [Mass/volume] in Blood
25
117
1.83
2.08
31.0
32.7
ug/l
7.2
7.2
0.03
19
105
(3051101) Glucose [Moles/volume] in Cord blood
8
167
0.41
2.05
3.4
6.7
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
124
0.34
2.03
1.0
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
15
59
2.18
1.99
1.1
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
88
1003
0.75
1.98
1.1
1.3
u/l
43.1
31.1
0.54
74
857
(21494567) Legionella sp IgM Ab [Presence] in Serum
6
13
3.95
1.97
1.3
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
6
13
3.95
1.97
1.3
1.0
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
107
700
1.31
1.96
1.1
1.3
nmol/l
0.7
2.7
0.71
101
671
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
98
1097
0.76
1.95
2.0
1.6
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
107
703
1.31
1.91
1.1
1.3
nmol/l
0.1
0.3
—
9
56
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
120
0.36
1.90
3.8
9.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
51
296
1.48
1.89
1.5
1.6
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
32
434
0.63
1.87
1.1
1.1
u/ml
3.6
3.3
—
9
127
(3042733) HLA Ab [Presence] in Serum
20
91
1.88
1.84
3.1
4.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
2212
18024
1.07
1.83
3.1
3.0
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
9
29
2.66
1.83
1.1
1.1
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
7
19
3.15
1.82
1.0
1.5
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
19
3.15
1.82
1.0
1.2
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
10
34
2.52
1.80
1.2
1.2
nmol/l
0.1
0.1
—
5
22
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
30
156
1.65
1.79
2.4
1.6
ug/l
38.7
62.6
2.99
30
151
(3037556) Urate [Mass/volume] in Serum or Plasma
14
235
0.51
1.78
2.1
1.4
—
—
—
0
0
(4133840)
19
86
1.89
1.78
1.3
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
111
742
1.28
1.76
1.1
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
118
0.36
1.76
1.6
1.5
ug/l
11.8
9.5
—
5
118
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
11
40
2.35
1.74
1.0
1.1
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
58
352
1.41
1.73
1.2
1.2
u/ml
1.4
65.3
—
5
15
(3019832) Treponema pallidum Ab [Presence] in Serum
127
1353
0.80
1.73
1.2
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
69
432
1.37
1.72
1.3
1.5
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
18
81
1.90
1.72
1.0
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
8
153
0.45
1.71
1.0
1.1
miu/ml
1891.0
1735.4
—
8
153
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
56
340
1.41
1.68
1.2
1.2
u/ml
29.6
46.4
—
8
21
(4198724)
13
52
2.14
1.68
1.5
1.1
—
—
—
0
0
(4306422)
77
494
1.34
1.66
1.2
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
127
0.40
1.65
1.3
1.5
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
7
21
2.85
1.65
2.0
8.8
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
60
371
1.39
1.63
1.1
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
134
1405
0.81
1.60
2.1
2.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
53
322
1.41
1.60
1.2
1.2
u/ml
2.4
3.2
—
5
22
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
28
148
1.62
1.60
1.1
1.2
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
5
12
3.56
1.58
2.6
1.3
nmol/l
4.7
5.2
—
5
12
(3009466) Valproate [Moles/volume] in Serum or Plasma
81
529
1.31
1.56
3.8
3.9
umol/l
355.3
346.3
0.22
69
425
(3016650) Hepatitis A virus Ab [Presence] in Serum
91
604
1.29
1.56
1.1
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
7
137
0.44
1.55
9.3
8.9
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
13
54
2.06
1.54
1.8
1.6
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
55
339
1.39
1.54
1.2
1.2
u/ml
51.6
64.2
—
8
13
(3034426) Prothrombin time (PT)
22
110
1.71
1.54
1.1
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
267
2623
0.87
1.52
1.2
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
91
607
1.28
1.51
1.1
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
85
563
1.29
1.50
1.1
1.2
u/ml
302.5
274.9
0.42
55
348
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
6
18
2.85
1.47
1.0
1.2
%
106.0
107.4
—
6
18
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
49
300
1.40
1.44
1.1
1.1
—
27.2
—
0
5
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
16
74
1.85
1.44
1.0
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
40
236
1.45
1.43
1.1
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
101
689
1.26
1.42
1.4
1.4
mu/l
117.3
59.8
0.87
81
605
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
78
516
1.30
1.40
1.1
1.1
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
5
14
3.05
1.38
1.0
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
43
260
1.42
1.37
2.3
2.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
23
121
1.63
1.36
1.5
1.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
32
0.00
1.35
0.0
4.6
—
—
—
0
0
(4268621)
51
319
1.37
1.34
2.1
2.2
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
6
20
2.57
1.32
1.0
1.0
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
10
40
2.14
1.31
1.6
2.5
%
3.8
15.9
—
5
24
(3016018) Differential panel - Cerebral spinal fluid
73
484
1.29
1.31
1.2
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
536
5002
0.91
1.31
4.8
2.6
ml/min/173m2
61.4
61.4
0.02
236
2026
(3019309) Folate [Moles/volume] in Red Blood Cells
1403
12624
0.94
1.31
1.7
1.7
nmol/l
1075.0
1159.7
2.75
1049
9284
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
40
241
1.42
1.31
1.1
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
15
2.85
1.29
1.0
1.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
30
171
1.50
1.29
1.2
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
8
137
0.50
1.25
1.0
1.5
ng/l
158.1
145.3
—
8
137
(3017704) Immunofixation for Urine
45
280
1.38
1.24
1.6
1.5
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
29
166
1.50
1.23
1.0
1.0
iu/ml
6.3
12.3
—
9
42
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
41
252
1.39
1.22
1.3
1.5
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
12
184
0.56
1.21
1.5
1.5
ug/l
8.8
9.4
0.09
12
172
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
47
538
0.75
1.20
1.4
1.5
%
23.4
28.4
0.54
30
319
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
37
224
1.41
1.20
1.0
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
60
663
0.77
1.20
1.9
1.4
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
6
22
2.33
1.18
1.0
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
37
225
1.41
1.17
1.0
1.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
102
715
1.22
1.17
1.2
1.2
u/ml
63.5
48.3
0.29
14
74
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
133
960
1.19
1.14
1.2
1.2
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
52
338
1.32
1.11
2.4
2.1
ug/min
86.2
167.7
—
9
95
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
7
26
2.30
1.11
1.1
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
41
257
1.37
1.11
1.9
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
41
257
1.37
1.11
1.9
1.4
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
26
321
0.69
1.08
1.6
1.6
—
75.1
—
0
24
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
11
50
1.88
1.07
1.5
2.4
%
52.2
63.4
—
6
35
(40758358) Immune stain study
5
18
2.38
1.07
1.0
1.0
—
—
—
0
0
(3016750) Collection duration of Urine
37
428
0.74
1.05
2.1
2.0
min
506.8
502.9
0.09
26
320
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
23
131
1.50
1.03
1.2
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
436
3428
1.09
1.02
3.9
2.9
e9/l
5.2
4.0
8.35
330
2455
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
37
232
1.37
1.02
1.1
1.5
u/l
11.7
6.9
0.52
30
196
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
32
196
1.40
1.01
1.4
1.6
nmol/l
16.2
3.5
0.48
27
171
(1761482) Bacteria [#/volume] in Urine by Culture
210
2023
0.88
0.99
4.4
3.9
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
7
116
0.52
0.99
1.1
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
89
629
1.21
0.99
1.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
20
112
1.53
0.97
1.1
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
42
271
1.33
0.97
4.1
6.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
72
754
0.82
0.96
1.1
1.1
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
7
31
1.93
0.95
3.7
3.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
34
213
1.37
0.95
1.8
1.7
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
20
113
1.51
0.94
1.1
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2796
24534
0.96
0.93
2.6
2.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
4844
42081
0.97
0.92
5.1
3.5
mm/h
22.4
12.2
170.07
4588
37969
(3024471) HLA-A [Type]
18
100
1.54
0.92
1.1
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
32
368
0.74
0.90
1.1
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
46
305
1.29
0.90
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
136
1009
1.15
0.89
1.3
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
23
136
1.45
0.89
1.2
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
31
194
1.37
0.89
1.1
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
36
231
1.33
0.88
1.0
1.0
u/ml
4.9
2.9
0.27
15
83
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
6
25
2.05
0.88
1.2
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
11
54
1.74
0.87
1.5
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
19
109
1.49
0.85
1.1
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
60
629
0.81
0.84
2.1
2.2
ml
671.3
666.9
0.02
39
415
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
54
370
1.25
0.83
3.4
4.7
u/ml
62.5
73.4
0.09
16
112
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
99
723
1.17
0.81
2.9
1.9
mg/l
30.5
31.3
0.04
32
168
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
188
1795
0.89
0.81
1.2
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
84
605
1.19
0.81
1.2
1.3
nmol/l
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
35
228
1.31
0.80
1.1
1.0
u/ml
0.4
1.5
0.91
17
78
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
16
90
1.52
0.79
1.0
1.1
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
16
90
1.52
0.79
1.1
1.2
umol/24h
0.6
0.7
—
5
38
(3032868) Hemoglobin electrophoresis panel in Blood
0
23
0.00
0.78
0.0
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
37
244
1.30
0.78
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
355
3277
0.92
0.77
3.0
2.8
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
24
148
1.39
0.77
1.2
1.6
g/l
13.8
11.9
0.41
17
114
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
99
982
0.86
0.77
2.8
2.9
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
56
390
1.23
0.76
1.0
1.1
au/ml
7.2
14.1
—
6
19
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
41
275
1.28
0.76
2.0
2.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
17
98
1.48
0.76
1.1
1.1
—
—
—
0
0
(3001729) Color of Synovial fluid
10
50
1.71
0.76
1.5
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
122
912
1.15
0.75
1.2
1.3
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
24
278
0.74
0.74
1.2
1.3
nmol/l
1.4
1.2
0.42
18
208
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
5
21
2.04
0.73
1.2
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
5
21
2.04
0.73
1.2
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
17
99
1.47
0.73
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
17
99
1.47
0.73
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
17
99
1.47
0.73
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
17
99
1.47
0.73
1.1
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
48
1.60
0.72
1.0
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
39
263
1.27
0.71
1.1
1.1
u/ml
0.5
1.0
0.89
16
78
(3020123) Porphyrins [Interpretation] in Serum or Plasma
5
22
1.94
0.71
1.0
1.0
—
—
—
0
0
(4212803)
9
49
1.57
0.70
1.1
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
49
1.57
0.70
1.0
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
62
442
1.20
0.69
1.2
1.4
—
—
—
0
0
(44806071)
7
37
1.62
0.66
1.3
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
24
153
1.34
0.65
1.2
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
23
146
1.35
0.64
2.6
1.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
585
4749
1.06
0.64
1.3
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
12
152
0.67
0.63
1.3
1.4
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
13
162
0.69
0.63
2.0
2.2
ug/l
7.4
3.0
—
5
48
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
17
103
1.41
0.62
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
85
631
1.15
0.62
1.4
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
39
269
1.24
0.61
1.0
1.2
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
17
0.00
0.61
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
21
133
1.35
0.60
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
223
1755
1.09
0.60
1.2
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
592
4821
1.05
0.59
3.9
3.7
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
88
658
1.15
0.59
1.2
1.3
pmol/l
261.8
284.4
0.17
64
494
(3027874) Urate [Moles/volume] in Urine
0
20
0.00
0.59
0.0
1.1
—
1.8
—
0
14
(3007164) IgA [Mass/volume] in Serum or Plasma
896
7957
0.96
0.58
1.4
1.4
g/l
2.7
2.6
0.72
513
4321
(3026389) Candida sp identified in Specimen by Organism specific culture
79
587
1.15
0.58
1.2
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
22
142
1.33
0.57
1.1
1.3
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
24
264
0.78
0.56
1.1
1.1
nmol/l
1.7
14.6
—
5
45
(3006270) Folate [Moles/volume] in Blood
55
553
0.85
0.56
1.2
1.2
nmol/l
299.4
329.8
0.56
37
439
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
91
686
1.14
0.55
1.1
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
14
84
1.43
0.55
1.5
1.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
12
70
1.47
0.53
1.1
1.1
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
10
56
1.53
0.53
5.2
4.8
ug/min
83.2
45.5
—
10
46
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
17
107
1.36
0.52
1.1
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
25
270
0.79
0.52
1.2
1.4
nmol/l
0.2
0.2
0.65
17
198
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
67
657
0.87
0.51
1.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
41
292
1.20
0.51
1.4
1.6
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
7
38
1.58
0.49
1.0
1.2
—
25.1
—
0
11
(3012565) Volume of 24 hour Urine
39
278
1.20
0.48
2.0
2.3
ml
1593.6
1968.1
1.33
32
233
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
10
123
0.69
0.48
11.6
12.7
mmol/l
0.8
0.7
—
10
111
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
7
40
1.50
0.48
1.1
1.1
u/l
14.6
13.3
—
7
40
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
11
65
1.45
0.47
1.1
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
18
117
1.32
0.46
1.1
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
46
335
1.18
0.46
1.6
1.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
14
88
1.36
0.44
1.2
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
33
338
0.83
0.44
1.4
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
47
345
1.17
0.44
1.0
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
5
26
1.64
0.43
1.2
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
168
1548
0.93
0.43
1.3
1.4
ug/g
268.6
258.4
0.27
102
944
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
80
0.64
0.42
1.5
1.8
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
80
0.64
0.42
2.5
3.0
u/field
0.2
0.3
—
6
80
(3035933) Granulocytes/100 leukocytes in Blood
6
80
0.64
0.42
1.0
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
29
204
1.22
0.42
1.1
1.1
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
13
0.00
0.41
0.0
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
174
1384
1.08
0.41
1.8
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
48
355
1.16
0.41
1.1
1.1
—
—
—
0
0
(3035510) Gentamicin [Mass/volume] in Serum or Plasma
0
14
0.00
0.41
0.0
5.9
—
0.8
—
0
9
(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid
0
14
0.00
0.41
0.0
5.8
—
17.9
—
0
14
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
14
0.00
0.41
0.0
1.1
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
14
0.00
0.41
0.0
5.8
—
449.2
—
0
14
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
38
381
0.85
0.41
1.3
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
11670.0
—
0
6
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
16
0.00
0.40
0.0
1.0
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
16
0.00
0.40
0.0
1.0
—
297.0
—
0
5
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
32
324
0.84
0.39
1.5
2.0
u/field
1.2
2.5
1.43
22
219
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
5
30
1.43
0.39
1.0
1.1
—
13.0
—
0
8
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
34
246
1.18
0.38
1.3
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
49
366
1.15
0.38
1.6
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
57
1.35
0.38
1.1
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
19
129
1.26
0.38
1.3
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
106
830
1.09
0.38
1.3
1.3
—
—
—
0
0
(4211845)
33
331
0.85
0.37
3.7
3.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
111
1031
0.92
0.36
1.2
1.4
e6/l
23216.4
1455.9
0.47
77
846
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
18
122
1.26
0.36
1.1
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
111
1030
0.92
0.36
1.2
1.4
e6/l
35.9
10.5
0.48
74
806
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
15
163
0.79
0.35
1.3
2.2
—
—
—
0
0
(3025315) Body weight
6
36
1.43
0.35
3.7
4.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
9
104
0.74
0.35
1.0
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
6
37
1.39
0.35
1.8
1.8
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
123
1.25
0.35
1.2
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
30
301
0.85
0.34
3.0
3.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
49
370
1.13
0.34
1.6
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
14
93
1.29
0.33
1.5
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
44
331
1.14
0.32
1.1
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
150
1368
0.94
0.32
1.6
1.5
e6/l
30111.1
13874.9
0.92
110
960
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
25
253
0.84
0.32
1.1
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
23
164
1.20
0.31
1.1
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
7
44
1.36
0.31
1.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
11
71
1.33
0.31
1.1
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
184
1664
0.94
0.31
1.8
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
78
610
1.09
0.31
1.2
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
38
285
1.14
0.30
1.8
1.7
u/l
16.8
1794.1
0.80
12
111
(1001926) Buprenorphine [Presence] in Urine by Screen method
37
277
1.14
0.30
1.6
1.3
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
11
121
0.78
0.29
1.3
1.4
%
178.5
203.0
0.57
11
114
(3043410) Blood group antigens tested for on Red Blood Cells
21
150
1.20
0.29
1.8
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
70
547
1.09
0.29
1.2
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
25
182
1.18
0.28
1.0
1.0
u/ml
1.0
1.0
—
5
32
(40768793) Breast Pathology biopsy report
108
990
0.93
0.28
1.2
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
13
88
1.26
0.27
1.0
1.3
—
—
—
0
0
(4281824)
73
574
1.09
0.27
1.2
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
5
63
0.68
0.26
1.2
1.5
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
40
382
0.89
0.25
1.2
1.2
mmol/l
12.1
11.9
0.04
13
124
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
9
62
1.24
0.25
6.4
10.1
mmol/l
5.7
5.5
—
9
62
(3037121) Protein [Mass/volume] in Urine
240
1968
1.04
0.25
2.5
2.7
g/l
0.3
0.3
0.68
125
794
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
9
63
1.22
0.25
1.1
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
12
127
0.81
0.24
1.0
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
23
169
1.16
0.24
1.1
1.0
u/l
1.0
1.1
0.69
14
81
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
14
145
0.83
0.24
1.7
2.7
mmol/l
6.5
7.6
—
7
97
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
49
460
0.91
0.24
1.1
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
48
373
1.10
0.23
1.6
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
131
1182
0.95
0.23
1.2
1.3
mg/l
774.2
528.1
0.63
124
1124
(3014148) Varicella zoster virus Ab [Titer] in Serum
41
316
1.11
0.23
1.1
1.1
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
23
170
1.16
0.23
2.3
2.0
e6/l
5442.0
4988.8
0.04
14
102
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
22
162
1.16
0.23
1.2
1.4
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
22
162
1.16
0.23
3.1
2.8
umol/l
31.2
28.2
0.72
17
126
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
33
1.30
0.23
1.2
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
14
144
0.83
0.23
1.0
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
58
538
0.92
0.22
1.4
1.3
e6/l
316211.7
126449.9
0.50
37
376
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
35
1.22
0.22
1.0
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
150
1345
0.95
0.22
3.9
3.0
mg/l
40.8
28.9
2.30
109
846
(3041672) Baker's yeast Ab [Presence] in Serum
0
9
0.00
0.21
0.0
1.1
—
—
—
0
0
(3017950) Salicylates [Moles/volume] in Serum or Plasma
0
9
0.00
0.21
0.0
1.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
9
0.00
0.21
0.0
6.2
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
9
0.00
0.21
0.0
1.1
—
2613.3
—
0
9
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
9
0.00
0.21
0.0
1.2
—
1.9
—
0
9
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
10
0.00
0.21
0.0
10.1
—
44.7
—
0
10
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.3
—
3.0
—
0
11
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013862) HLA-DP [Type]
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
0
12
0.00
0.20
0.0
1.3
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
12
0.00
0.20
0.0
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
41
1.25
0.20
1.2
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
9
97
0.79
0.20
1.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
52
481
0.92
0.19
1.3
1.5
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
6
44
1.17
0.19
1.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
6
44
1.17
0.19
1.0
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
44
1.17
0.19
1.0
1.5
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
26
198
1.12
0.18
2.2
2.1
e6/l
731.2
682.4
0.09
17
143
(3020491) Glucose [Moles/volume] in Blood
48
380
1.08
0.17
1.8
1.9
mmol/l
7.1
7.0
0.08
37
238
(3051593) INR in Capillary blood by Coagulation assay
39
363
0.92
0.17
8.8
13.7
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
58
0.74
0.17
1.6
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
58
0.74
0.17
1.6
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
58
0.74
0.17
1.6
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
58
0.74
0.17
1.6
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
71
572
1.06
0.17
1.1
1.2
miu/ml
162.3
229.2
0.75
15
190
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
17
166
0.88
0.16
1.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
60
1.14
0.16
1.1
1.2
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
27
209
1.10
0.15
1.2
3.3
mg/l
61.4
68.9
0.25
19
144
(3027944) Amphetamines [Presence] in Urine
46
366
1.08
0.15
1.6
1.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
11
111
0.85
0.15
1.0
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
11
79
1.19
0.15
2.1
1.5
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
69
1.12
0.15
1.1
1.1
—
—
—
0
0
(44813793)
24
185
1.11
0.15
1.1
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
23
218
0.90
0.15
1.0
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
139
1146
1.04
0.14
1.2
1.2
titre
168.7
197.8
0.13
15
85
(3021788) Differential panel - Synovial fluid
120
987
1.04
0.14
1.3
1.4
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
15
146
0.88
0.14
1.0
1.2
—
7.1
—
0
14
(3036071) Salmonella sp Ab [Titer] in Serum
12
119
0.86
0.14
1.0
1.1
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
24
186
1.10
0.13
2.6
2.4
—
31.0
—
0
5
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
11
109
0.86
0.12
1.7
2.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
24
187
1.10
0.12
1.0
1.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
866
7484
0.99
0.11
1.4
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
62
555
0.95
0.11
1.1
1.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
4545
38750
1.01
0.10
4.6
4.2
e6/l
159.6
1815.4
6.61
89
586
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
22
204
0.92
0.10
1.1
1.1
ratio
1.1
1.1
—
5
64
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
38
1.13
0.10
1.0
1.2
umol/24h
2.2
1.5
—
5
38
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
58
475
1.04
0.09
1.4
1.6
u/ml
23.1
23.1
0.00
14
103
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
46
1.12
0.09
9.8
6.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
46
1.12
0.09
1.7
1.4
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
30
241
1.06
0.08
1.2
1.7
—
5.0
—
0
9
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
49
1.05
0.08
1.2
1.0
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
408
3528
0.99
0.07
2.9
2.7
e6/l
0.3
0.3
0.10
402
3467
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
8
67
1.02
0.07
1.1
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
72
0.83
0.07
1.7
1.3
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
39
319
1.05
0.07
1.3
1.3
promille
1.2
1.2
0.03
29
244
(21494890) Protein electrophoresis panel - 24 hour Urine
76
632
1.03
0.06
1.7
1.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
26
210
1.06
0.06
1.2
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
20
182
0.94
0.05
1.1
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
35
287
1.04
0.05
1.7
1.6
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
11
103
0.91
0.05
1.0
1.3
%
94.0
81.7
—
6
50
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
119
1034
0.98
0.04
1.2
1.2
mmol/l
3.9
3.8
0.09
111
977
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
24
215
0.95
0.04
2.4
2.1
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
20
180
0.95
0.04
2.8
6.1
%
62.8
73.3
0.63
12
152
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
14
112
1.07
0.03
1.1
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
14
126
0.95
0.02
1.4
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
514
4405
1.00
0.01
1.8
1.6
%
1.9
1.5
7.67
410
3714
(3013166) Neutrophils/100 leukocytes in Synovial fluid
21
174
1.03
0.01
1.5
1.3
%
70.4
60.7
0.71
16
147
(44806420)
29
253
0.98
0.00
2.5
2.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
20
176
0.97
0.00
1.3
1.4
umol/l
16.0
14.6
0.04
11
125
(3023430) Cat dander IgE Ab [Units/volume] in Serum
18
149
1.03
0.00
1.1
1.0
u/ml
0.7
2.2
—
6
45
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
12
106
0.97
0.00
1.0
1.1
%
94.1
84.0
—
7
49
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
15
126
1.02
0.00
1.1
1.0
u/ml
0.3
0.1
—
5
23
(3034770) Mitochondria Ab [Titer] in Serum
134
1149
1.00
0.00
1.2
1.2
titre
664.3
627.7
—
7
35
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
15
125
1.03
0.00
1.1
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
10
90
0.95
0.00
1.0
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
19
159
1.02
0.00
1.1
1.0
u/ml
12.6
1.1
—
5
46
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
38
321
1.01
0.00
1.1
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
64
0.94
0.00
1.1
1.5
—
—
—
0
0
(3032333) Phosphate [Mass or Moles] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
7.1
—
0.3
—
0
7
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
48
0.89
0.00
1.0
1.0
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
6
0.00
0.00
0.0
8.2
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
7
67
0.89
0.00
1.7
2.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
56
0.92
0.00
1.0
1.1
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
3.1
—
2.3
—
0
8
(3002079) Sodium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
135.9
—
0
5
(3034092) Cytoplasmic Ig cells/100 cells in Blood
6
57
0.90
0.00
14.5
7.1
—
—
—
0
0
(3003095) Rheumatoid factor [Units/volume] in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
66
0.91
0.00
1.6
2.2
—
—
—
0
0
(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count
0
6
0.00
0.00
0.0
7.8
—
0.7
—
0
6
(3009220) Epithelial cells.squamous [#/volume] in Urine sediment
0
5
0.00
0.00
0.0
1.2
—
3.0
—
0
5
(3034614) HLA Ag [Interpretation]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
5
43
0.99
0.00
1.4
1.2
mmol/l
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
5
45
0.95
0.00
1.8
2.4
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
5
43
0.99
0.00
1.4
1.2
mmol/l
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
9
83
0.93
0.00
1.1
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: LUNG_CANCER_MESOT – Lung cancer and mesothelioma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).